≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other endophthalmitis

DOID Endpoint Browser PheWeb

H7_OTHENDOPHTHALMITIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

209

4. Check minimum number of events

None

209

5. Include endpoints

None

209

6. Filter based on genotype QC (FinnGen only)

204

Control definitions (FinnGen only)

Control exclude
H7_VITREOUS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1770 938 814
Only index persons 1405 776 629
Unadjusted period prevalence (%)
Whole population 0.02 0.03 0.02
Only index persons 0.03 0.03 0.02
Median age at first event (years)
Whole population 66.80 71.11 61.85
Only index persons 65.42 70.24 59.47

-FinnGen-

Key figures

All Female Male
Number of individuals 204 117 87
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 64.11 64.89 63.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
209
Matched controls
2090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H44.1
ICD-10 Finland
Other endophthalmitis
+∞
231.7
177
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
34.0
136.0
102
57
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
55.9
106.8
63
16
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
19.3
62.8
54
37
CKA10
NOMESCO Finland
Biopsy of vitreous body
+∞
62.7
57
*
H44.0
ICD-10 Finland
Purulent endophthalmitis
+∞
61.6
56
*
WX140
NOMESCO Finland
Parabulbar anesthesy
15.4
59.6
59
52
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.3
36.0
65
121
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.9
34.5
91
243
XCW99
NOMESCO Finland
Other investigative procedure of eye
6.8
32.8
63
124
S01ED51
ATC
timolol, combinations; ophthalmic
7.4
32.1
55
96
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
9.0
30.0
41
55
S01ED01
ATC
timolol; ophthalmic
12.0
28.7
31
30
H43.1
ICD-10 Finland
Vitreous haemorrhage
+∞
27.7
26
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
8.4
26.4
38
54
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.8
25.4
81
245
H20.1
ICD-10 Finland
Chronic iridocyclitis
102.9
25.3
27
*
XCK10
NOMESCO Finland
Photography of fundus of eye
5.5
23.2
54
125
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
4.0
21.7
128
590
XCH00
NOMESCO Finland
Eye pressure measurement
6.6
17.7
31
54
H33.0
ICD-10 Finland
Retinal detachment with retinal break
16.0
17.4
28
20
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
28.5
17.3
23
9
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.4
17.0
125
633
H26.4
ICD-10 Finland
After-cataract
4.3
17.0
53
153
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.4
15.9
46
125
S01EE01
ATC
latanoprost; ophthalmic
5.3
15.3
34
74
TCK20
NOMESCO Finland
Needle biopsy of vitreous body
+∞
14.8
14
*
36609
ICD-8 Finland
Other inflammation of uveal tract, Unspecified
+∞
14.8
14
*
H43.8
ICD-10 Finland
Other disorders of vitreous body
15.2
13.6
22
16
WX142
NOMESCO Finland
Sub-tenon anesthesy
43.1
13.4
16
*
H16.0
ICD-10 Finland
Corneal ulcer
5.9
13.1
25
47
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
28.7
12.2
16
6
114
Kela drug reimbursment
Glaucoma
3.8
11.7
41
127
S01EA05
ATC
brimonidine; ophthalmic
12.9
11.6
20
17
TCH12
NOMESCO Finland
Sample aspiration from anterior chambre
+∞
11.6
11
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
126.7
11.5
12
*
CKD40
NOMESCO Finland
Endophotocoagulation of retina
16.3
11.5
18
12
XCK00
NOMESCO Finland
Perimetry
4.6
11.5
29
70
CKC12
NOMESCO Finland
Photocoagulation of retina
10.1
11.3
22
24
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
21.5
11.3
16
8
H02AB06
ATC
prednisolone; systemic
2.7
11.2
128
766
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
29.8
10.9
14
5
H25.1
ICD-10 Finland
Senile nuclear cataract
2.7
10.8
101
545
XCD20
NOMESCO Finland
Photoangiography of eye
11.5
10.5
19
18
H3603, E103,
ICD-10 Finland
115.6
10.5
11
*
S01BC03
ATC
diclofenac; ophthalmic
14.1
10.4
17
13
S01EC01
ATC
acetazolamide; systemic
8.8
10.1
21
26
H26.2
ICD-10 Finland
Complicated cataract
42.2
10.1
12
*
WX002
NOMESCO Finland
Sedation and analgesia
2.9
10.0
59
250
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
10.0
121
732
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
21.3
9.9
14
7
A10AA02, ,
ATC
5.7
9.8
19
36
S01BA04
ATC
prednisolone; ophthalmic
9.8
9.8
19
21
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
12.2
9.8
17
15
ZXD05
NOMESCO Finland
Urgent procedure
2.5
9.3
80
409
H40.0
ICD-10 Finland
Glaucoma suspect
3.9
9.2
29
83
S01BA07
ATC
fluorometholone; ophthalmic
14.9
8.8
14
10
S01EE05
ATC
tafluprost; ophthalmic
7.0
8.7
21
33
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
93.7
8.5
9
*
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
93.7
8.5
9
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
+∞
8.4
8
*
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
+∞
8.4
8
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
10.7
8.2
15
15
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
3.6
8.2
29
90
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
6.4
7.9
20
34
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.8
7.8
46
193
Z3229
NOMESCO Finland
Other healthcare associate professional
3.3
7.8
32
109
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
9.4
7.7
15
17
ZXA00
NOMESCO Finland
Right side
2.4
7.7
76
408
CKC15
NOMESCO Finland
Panretinal photocoagulation
26.1
7.6
10
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
26.1
7.6
10
*
ZX198
NOMESCO Finland
Other local administration
26.1
7.6
10
*
S01BA01
ATC
dexamethasone; ophthalmic
6.4
7.6
19
32
36608
ICD-8 Finland
Other inflammation of uveal tract, Alia definita
+∞
7.3
7
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
7.3
7
*
S01EA03
ATC
apraclonidine; ophthalmic
16.5
7.3
11
7
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
31.2
7.2
9
*
H30.2
ICD-10 Finland
Posterior cyclitis
31.2
7.2
9
*
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
10.6
7.1
13
13
H35.6
ICD-10 Finland
Retinal haemorrhage
14.4
7.0
11
8
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
8.7
6.9
14
17
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
17.4
6.8
10
6
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
6.8
53
254
127
Kela drug reimbursment
Transplant complication
23.4
6.7
9
*
H21.0
ICD-10 Finland
Hyphaema
72.0
6.5
7
*
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
72.0
6.5
7
*
H20.8
ICD-10 Finland
Other iridocyclitis
72.0
6.5
7
*
A10AA01, ,
ATC
6.6
6.3
15
24
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
+∞
6.3
6
*
TCH10
NOMESCO Finland
Needle aspiration of aqueous from anterior chamber
+∞
6.3
6
*
H44.5
ICD-10 Finland
Degenerated conditions of globe
+∞
6.3
6
*
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
27.6
6.3
8
*
ZXA05
NOMESCO Finland
Left side
2.2
6.1
64
347
H34.8
ICD-10 Finland
Other retinal vascular occlusions
6.4
6.1
15
25
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
6.0
54
274
A10AB01
ATC
insulin (human); parenteral
5.3
6.0
17
34

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Ophthalmology
18 [38004463]
1.5e+00
3.0e+00
4.6e+00
—
5.4e+00
3.9e+00
2.0e+00
cases:50.26%
controls:18.41%
cases:60.73%
controls:7.42%
cases:59.69%
controls:1.42%
—
—
cases:76.96%
controls:1.43%
cases:81.46%
controls:8.02%
cases:65.73%
controls:20.90%
96
350
95
1551
116
141
75
1760
114
27
77
1874
—
147
27
44
1867
145
145
33
1662
94
298
49
1128
Puncture of vitreous body with injection of medication
CKD05 [2001301407]
3.8e+00
3.8e+00
4.4e+00
—
—
3.9e+00
2.7e+00
cases:15.71%
controls:0.42%
cases:20.94%
controls:0.58%
cases:17.80%
controls:0.26%
—
—
—
—
cases:15.73%
controls:0.39%
cases:15.38%
controls:1.19%
30
8
161
1893
40
11
151
1890
34
5
157
1896
—
—
28
7
150
1800
22
17
121
1409
Senile macular degeneration (atrophic)(exudative)
H35.31 [2000502315]
3.0e+00
3.3e+00
4.0e+00
1.0e+50
—
2.9e+00
2.5e+00
cases:12.04%
controls:0.68%
cases:14.14%
controls:0.63%
cases:13.09%
controls:0.26%
cases:6.28%
controls:0.00%
—
—
cases:12.92%
controls:0.77%
cases:13.29%
controls:1.26%
23
13
168
1888
27
12
164
1889
25
5
166
1896
12
0
179
1901
—
23
14
155
1793
19
18
124
1408
Outpatient Visit
OP [9202]
4.4e-01
1.0e+00
2.0e+00
4.9e+00
2.4e+00
1.7e+00
9.1e-01
cases:79.06%
controls:70.80%
cases:72.25%
controls:47.76%
cases:44.50%
controls:9.52%
cases:37.17%
controls:0.42%
cases:53.93%
controls:9.61%
cases:84.27%
controls:49.47%
cases:88.81%
controls:76.16%
151
1346
40
555
138
908
53
993
85
181
106
1720
71
8
120
1893
103
182
88
1712
150
894
28
913
127
1086
16
340
timolol, combinations
S01ED51 [21603705]
1.4e+00
1.5e+00
1.8e+00
—
3.1e+00
2.0e+00
1.8e+00
cases:9.42%
controls:2.47%
cases:9.95%
controls:2.42%
cases:5.24%
controls:0.95%
—
—
cases:9.42%
controls:0.48%
cases:15.17%
controls:2.32%
cases:11.89%
controls:2.24%
18
47
173
1854
19
46
172
1855
10
18
181
1883
—
18
9
173
1885
27
42
151
1765
17
32
126
1394
Other investigative procedure of eye
XCW99 [2001301491]
2.0e+00
3.2e+00
—
1.0e+50
1.0e+50
3.2e+00
2.0e+00
cases:9.95%
controls:1.53%
cases:10.47%
controls:0.47%
—
—
cases:4.19%
controls:0.00%
cases:7.33%
controls:0.00%
cases:12.36%
controls:0.55%
cases:13.29%
controls:2.03%
19
29
172
1872
20
9
171
1892
—
8
0
183
1901
14
0
177
1894
22
10
156
1797
19
29
124
1397
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
1.7e+00
2.6e+00
—
—
—
3.6e+00
2.1e+00
cases:7.85%
controls:1.53%
cases:8.38%
controls:0.68%
—
—
—
—
—
—
cases:15.17%
controls:0.50%
cases:10.49%
controls:1.40%
15
29
176
1872
16
13
175
1888
—
—
—
27
9
151
1798
15
20
128
1406
antibiotics in combination with other drugs
S01AA20 [21603571]
6.4e-01
2.0e+00
—
—
4.8e+00
2.9e+00
5.5e-01
cases:15.71%
controls:8.94%
cases:15.71%
controls:2.42%
—
—
—
—
cases:24.08%
controls:0.26%
cases:28.09%
controls:2.16%
cases:16.08%
controls:9.96%
30
170
161
1731
30
46
161
1855
—
—
46
5
145
1889
50
39
128
1768
23
142
120
1284
Senile nuclear cataract
H25.1 [45581628]
5.4e-01
1.7e+00
3.6e+00
1.0e+50
2.5e+00
1.8e+00
1.7e-02
cases:9.42%
controls:5.73%
cases:9.42%
controls:1.84%
cases:10.47%
controls:0.32%
cases:3.66%
controls:0.00%
cases:3.66%
controls:0.32%
cases:11.24%
controls:1.99%
cases:7.69%
controls:7.57%
18
109
173
1792
18
35
173
1866
20
6
171
1895
7
0
184
1901
7
6
184
1888
20
36
158
1771
11
108
132
1318
dorzolamide
S01EC03 [21603695]
1.7e+00
2.3e+00
—
—
—
2.9e+00
2.4e+00
cases:5.24%
controls:1.00%
cases:6.81%
controls:0.74%
—
—
—
—
—
—
cases:11.24%
controls:0.66%
cases:7.69%
controls:0.77%
10
19
181
1882
13
14
178
1887
—
—
—
20
12
158
1795
11
11
132
1415
Examination of eyes and vision
Z01.0 [45566391]
1.5e+00
2.8e+00
—
1.0e+50
1.0e+50
3.2e+00
1.5e+00
cases:7.85%
controls:1.89%
cases:10.47%
controls:0.74%
—
—
cases:4.19%
controls:0.00%
cases:9.95%
controls:0.00%
cases:14.61%
controls:0.66%
cases:13.29%
controls:3.23%
15
36
176
1865
20
14
171
1887
—
8
0
183
1901
19
0
172
1894
26
12
152
1795
19
46
124
1380
Nephrology
39 [38004479]
2.0e+00
2.2e+00
—
—
2.6e+00
2.1e+00
1.4e+00
cases:5.24%
controls:0.74%
cases:5.24%
controls:0.63%
—
—
—
—
cases:4.19%
controls:0.32%
cases:3.93%
controls:0.50%
cases:4.90%
controls:1.26%
10
14
181
1887
10
12
181
1889
—
—
8
6
183
1888
7
9
171
1798
7
18
136
1408
Phakoemulsification with implantation of artificial lens in posterior chamber
CJE20 [2001301342]
2.7e-01
2.0e+00
4.2e+00
—
—
2.2e+00
-2.7e-01
cases:8.90%
controls:6.94%
cases:8.38%
controls:1.26%
cases:14.66%
controls:0.26%
—
—
—
—
cases:12.92%
controls:1.55%
cases:6.99%
controls:8.98%
17
132
174
1769
16
24
175
1877
28
5
163
1896
—
—
23
28
155
1779
10
128
133
1298
prednisolone
S01BA04 [21603621]
1.2e+00
2.7e+00
—
1.0e+50
—
3.9e+00
1.8e+00
cases:5.24%
controls:1.68%
cases:6.81%
controls:0.47%
—
—
cases:5.76%
controls:0.00%
—
—
cases:19.66%
controls:0.50%
cases:9.79%
controls:1.82%
10
32
181
1869
13
9
178
1892
—
11
0
180
1901
—
35
9
143
1798
14
26
129
1400
prednisolone
S03BA02 [21605202]
1.2e+00
2.7e+00
—
1.0e+50
—
3.9e+00
1.8e+00
cases:5.24%
controls:1.68%
cases:6.81%
controls:0.47%
—
—
cases:5.76%
controls:0.00%
—
—
cases:19.66%
controls:0.50%
cases:9.79%
controls:1.82%
10
32
181
1869
13
9
178
1892
—
11
0
180
1901
—
35
9
143
1798
14
26
129
1400
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
2.5e+00
3.0e+00
—
—
—
2.8e+00
—
cases:6.28%
controls:0.53%
cases:5.76%
controls:0.32%
—
—
—
—
—
—
cases:5.06%
controls:0.33%
—
—
12
10
179
1891
11
6
180
1895
—
—
—
9
6
169
1801
—
Outpatient Hospital
22 [8756]
3.7e-01
1.2e+00
2.7e+00
—
2.4e+00
1.7e+00
4.9e-01
cases:33.51%
controls:25.78%
cases:18.85%
controls:6.58%
cases:10.47%
controls:0.79%
—
—
cases:10.99%
controls:1.16%
cases:25.84%
controls:6.14%
cases:31.47%
controls:21.95%
64
490
127
1411
36
125
155
1776
20
15
171
1886
—
21
22
170
1872
46
111
132
1696
45
313
98
1113
insulin glargine; parenteral
A10AE04 [21600739]
1.3e+00
1.5e+00
1.8e+00
—
—
1.4e+00
1.2e+00
cases:9.42%
controls:2.63%
cases:8.90%
controls:2.21%
cases:3.66%
controls:0.63%
—
—
—
—
cases:9.55%
controls:2.43%
cases:10.49%
controls:3.37%
18
50
173
1851
17
42
174
1859
7
12
184
1889
—
—
17
44
161
1763
15
48
128
1378
insulin (beef); parenteral
A10AD02 [21600730]
1.3e+00
1.5e+00
1.8e+00
—
—
1.4e+00
1.2e+00
cases:9.42%
controls:2.63%
cases:8.90%
controls:2.21%
cases:3.66%
controls:0.63%
—
—
—
—
cases:9.55%
controls:2.43%
cases:10.49%
controls:3.37%
18
50
173
1851
17
42
174
1859
7
12
184
1889
—
—
17
44
161
1763
15
48
128
1378
dexamethasone
S03BA01 [21605201]
5.6e-01
2.4e+00
—
—
—
3.3e+00
1.5e+00
cases:5.24%
controls:3.05%
cases:6.81%
controls:0.63%
—
—
—
—
—
—
cases:16.85%
controls:0.77%
cases:10.49%
controls:2.59%
10
58
181
1843
13
12
178
1889
—
—
—
30
14
148
1793
15
37
128
1389
dexamethasone
S01BA01 [21603618]
5.6e-01
2.4e+00
—
—
—
3.3e+00
1.5e+00
cases:5.24%
controls:3.05%
cases:6.81%
controls:0.63%
—
—
—
—
—
—
cases:16.85%
controls:0.77%
cases:10.49%
controls:2.59%
10
58
181
1843
13
12
178
1889
—
—
—
30
14
148
1793
15
37
128
1389
Eye pressure measurement
XCH00 [2001301234]
2.0e+00
2.3e+00
—
—
—
2.7e+00
2.0e+00
cases:3.66%
controls:0.53%
cases:4.19%
controls:0.42%
—
—
—
—
—
—
cases:6.18%
controls:0.44%
cases:3.50%
controls:0.49%
7
10
184
1891
8
8
183
1893
—
—
—
11
8
167
1799
5
7
138
1419
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
7.9e-01
2.5e+00
—
—
—
2.8e+00
1.6e+00
cases:2.62%
controls:1.21%
cases:3.66%
controls:0.32%
—
—
—
—
—
—
cases:4.49%
controls:0.28%
cases:6.29%
controls:1.33%
5
23
186
1878
7
6
184
1895
—
—
—
8
5
170
1802
9
19
134
1407
Presence of intraocular lens
Z96.1 [45585885]
7.4e-01
1.9e+00
—
1.0e+50
—
3.0e+00
2.0e+00
cases:5.76%
controls:2.84%
cases:5.76%
controls:0.95%
—
—
cases:8.38%
controls:0.00%
—
—
cases:19.66%
controls:1.16%
cases:20.98%
controls:3.44%
11
54
180
1847
11
18
180
1883
—
16
0
175
1901
—
35
21
143
1786
30
49
113
1377
Emergency Room Visit
ER [9203]
7.5e-01
1.1e+00
2.0e+00
—
2.0e+00
1.0e+00
4.5e-01
cases:51.31%
controls:33.19%
cases:28.80%
controls:11.68%
cases:13.61%
controls:2.05%
—
—
cases:9.95%
controls:1.53%
cases:26.97%
controls:11.46%
cases:45.45%
controls:34.64%
98
631
93
1270
55
222
136
1679
26
39
165
1862
—
19
29
172
1865
48
207
130
1600
65
494
78
932
chloramphenicol
S03AA08 [21605197]
6.2e-01
1.2e+00
—
—
3.8e+00
1.6e+00
3.9e-01
cases:10.99%
controls:6.21%
cases:8.38%
controls:2.63%
—
—
—
—
cases:10.47%
controls:0.26%
cases:9.55%
controls:2.05%
cases:9.79%
controls:6.87%
21
118
170
1783
16
50
175
1851
—
—
20
5
171
1889
17
37
161
1770
14
98
129
1328
chloramphenicol
S01AA01 [21603554]
6.2e-01
1.2e+00
—
—
3.8e+00
1.6e+00
3.9e-01
cases:10.99%
controls:6.21%
cases:8.38%
controls:2.63%
—
—
—
—
cases:10.47%
controls:0.26%
cases:9.55%
controls:2.05%
cases:9.79%
controls:6.87%
21
118
170
1783
16
50
175
1851
—
—
20
5
171
1889
17
37
161
1770
14
98
129
1328
latanoprost
S01EE01 [21603710]
1.4e+00
1.3e+00
—
—
2.6e+00
1.3e+00
1.1e+00
cases:7.85%
controls:2.05%
cases:7.33%
controls:2.10%
—
—
—
—
cases:4.19%
controls:0.32%
cases:7.87%
controls:2.32%
cases:7.69%
controls:2.73%
15
39
176
1862
14
40
177
1861
—
—
8
6
183
1888
14
42
164
1765
11
39
132
1387
Inpatient Hospital
21 [8717]
4.5e-01
8.8e-01
1.9e+00
—
2.2e+00
1.3e+00
4.6e-01
cases:44.50%
controls:33.93%
cases:23.04%
controls:11.05%
cases:10.47%
controls:1.68%
—
—
cases:14.66%
controls:1.90%
cases:30.90%
controls:10.96%
cases:41.26%
controls:30.79%
85
645
106
1256
44
210
147
1691
20
32
171
1869
—
28
36
163
1858
55
198
123
1609
59
439
84
987
Photography of fundus of eye
XCK10 [2001301381]
1.4e+00
2.1e+00
—
—
—
2.8e+00
1.6e+00
cases:5.24%
controls:1.37%
cases:2.62%
controls:0.32%
—
—
—
—
—
—
cases:6.18%
controls:0.39%
cases:9.09%
controls:1.96%
10
26
181
1875
5
6
186
1895
—
—
—
11
7
167
1800
13
28
130
1398
Left side
ZXA05 [2001311347]
4.9e-01
2.0e+00
1.0e+50
1.0e+50
—
2.4e+00
1.2e+00
cases:5.24%
controls:3.26%
cases:5.76%
controls:0.79%
cases:5.76%
controls:0.00%
cases:5.24%
controls:0.00%
—
—
cases:8.99%
controls:0.89%
cases:10.49%
controls:3.58%
10
62
181
1839
11
15
180
1886
11
0
180
1901
10
0
181
1901
—
16
16
162
1791
15
51
128
1375
prednisolone; oral, parenteral
H02AB06 [21602734]
1.2e-01
1.1e+00
1.4e+00
1.0e+50
3.4e+00
8.9e-01
3.7e-01
cases:13.61%
controls:12.26%
cases:16.23%
controls:5.89%
cases:4.71%
controls:1.21%
cases:4.19%
controls:0.00%
cases:25.13%
controls:1.11%
cases:13.48%
controls:6.03%
cases:18.18%
controls:13.32%
26
233
165
1668
31
112
160
1789
9
23
182
1878
8
0
183
1901
48
21
143
1873
24
109
154
1698
26
190
117
1236
prednisolone
A07EA01 [21600653]
1.2e-01
1.1e+00
1.4e+00
1.0e+50
3.4e+00
8.9e-01
3.6e-01
cases:13.61%
controls:12.31%
cases:16.23%
controls:5.94%
cases:4.71%
controls:1.21%
cases:4.19%
controls:0.00%
cases:25.13%
controls:1.16%
cases:13.48%
controls:6.03%
cases:18.18%
controls:13.39%
26
234
165
1667
31
113
160
1788
9
23
182
1878
8
0
183
1901
48
22
143
1872
24
109
154
1698
26
191
117
1235
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
4.3e-02
4.9e-01
7.6e-01
3.1e+00
1.4e+00
7.4e-01
1.6e-01
cases:28.27%
controls:27.41%
cases:25.65%
controls:17.46%
cases:7.85%
controls:3.84%
cases:5.76%
controls:0.26%
cases:13.09%
controls:3.64%
cases:29.21%
controls:16.44%
cases:34.97%
controls:31.49%
54
521
137
1380
49
332
142
1569
15
73
176
1828
11
5
180
1896
25
69
166
1825
52
297
126
1510
50
449
93
977
combinations of corticosteroids
D07AB30 [21602118]
3.8e-01
5.5e-01
2.1e+00
—
3.1e+00
1.1e-01
2.5e-01
cases:15.18%
controls:10.89%
cases:6.81%
controls:4.05%
cases:3.66%
controls:0.47%
—
—
cases:8.90%
controls:0.42%
cases:5.06%
controls:4.54%
cases:14.69%
controls:11.85%
29
207
162
1694
13
77
178
1824
7
9
184
1892
—
17
8
174
1886
9
82
169
1725
21
169
122
1257
combinations of corticosteroids
D07XB30 [21602188]
3.8e-01
5.5e-01
2.1e+00
—
3.1e+00
1.1e-01
2.5e-01
cases:15.18%
controls:10.89%
cases:6.81%
controls:4.05%
cases:3.66%
controls:0.47%
—
—
cases:8.90%
controls:0.42%
cases:5.06%
controls:4.54%
cases:14.69%
controls:11.85%
29
207
162
1694
13
77
178
1824
7
9
184
1892
—
17
8
174
1886
9
82
169
1725
21
169
122
1257
Other specified counselling
Z71.8 [45581061]
8.5e-01
7.8e-01
2.3e+00
1.0e+50
2.8e+00
8.9e-01
8.2e-01
cases:8.90%
controls:4.00%
cases:4.71%
controls:2.21%
cases:4.19%
controls:0.42%
cases:2.62%
controls:0.00%
cases:5.76%
controls:0.37%
cases:6.74%
controls:2.88%
cases:9.79%
controls:4.56%
17
76
174
1825
9
42
182
1859
8
8
183
1893
5
0
186
1901
11
7
180
1887
12
52
166
1755
14
65
129
1361
Case Management Agency
251B00000X [38004193]
4.7e-02
2.1e-01
7.7e-01
3.5e+00
8.3e-01
1.7e-01
1.8e-01
cases:59.16%
controls:58.02%
cases:55.50%
controls:50.34%
cases:37.70%
controls:21.88%
cases:33.51%
controls:1.53%
cases:39.79%
controls:22.33%
cases:56.74%
controls:52.46%
cases:72.03%
controls:68.23%
113
1103
78
798
106
957
85
944
72
416
119
1485
64
29
127
1872
76
423
115
1471
101
948
77
859
103
973
40
453
timolol
S01ED01 [21603699]
1.5e+00
1.2e+00
1.2e+00
—
—
1.8e+00
1.7e+00
cases:7.85%
controls:1.89%
cases:5.24%
controls:1.68%
cases:2.62%
controls:0.84%
—
—
—
—
cases:8.43%
controls:1.55%
cases:7.69%
controls:1.47%
15
36
176
1865
10
32
181
1869
5
16
186
1885
—
—
15
28
163
1779
11
21
132
1405
brimonidine
S01EA05 [21603677]
—
2.2e+00
—
—
—
2.5e+00
—
—
—
cases:3.14%
controls:0.37%
—
—
—
—
—
—
cases:3.93%
controls:0.33%
—
—
—
6
7
185
1894
—
—
—
7
6
171
1801
—
brimonidine
S01GA07 [947915]
—
2.2e+00
—
—
—
2.5e+00
—
—
—
cases:3.14%
controls:0.37%
—
—
—
—
—
—
cases:3.93%
controls:0.33%
—
—
—
6
7
185
1894
—
—
—
7
6
171
1801
—
levofloxacin
S01AE05 [43534860]
9.4e-01
2.2e+00
—
—
—
2.4e+00
6.2e-01
cases:5.24%
controls:2.10%
cases:4.71%
controls:0.53%
—
—
—
—
—
—
cases:10.67%
controls:1.11%
cases:5.59%
controls:3.09%
10
40
181
1861
9
10
182
1891
—
—
—
19
20
159
1787
8
44
135
1382
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
7.9e-03
3.6e-01
5.5e-01
2.9e+00
1.6e+00
3.9e-01
2.5e-02
cases:30.89%
controls:30.72%
cases:30.89%
controls:23.72%
cases:8.90%
controls:5.31%
cases:4.71%
controls:0.26%
cases:19.90%
controls:4.65%
cases:32.02%
controls:24.13%
cases:38.46%
controls:37.87%
59
584
132
1317
59
451
132
1450
17
101
174
1800
9
5
182
1896
38
88
153
1806
57
436
121
1371
55
540
88
886
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-3.4e-02
3.5e-01
5.4e-01
2.9e+00
1.6e+00
4.0e-01
2.2e-02
cases:30.37%
controls:31.09%
cases:30.89%
controls:23.93%
cases:8.90%
controls:5.37%
cases:4.71%
controls:0.26%
cases:19.90%
controls:4.70%
cases:32.58%
controls:24.41%
cases:38.46%
controls:37.94%
58
591
133
1310
59
455
132
1446
17
102
174
1799
9
5
182
1896
38
89
153
1805
58
441
120
1366
55
541
88
885
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
6.6e-02
2.5e-01
3.6e-01
2.9e+00
1.6e+00
1.9e-01
1.6e-02
cases:24.61%
controls:23.41%
cases:21.99%
controls:17.94%
cases:5.76%
controls:4.10%
cases:4.71%
controls:0.26%
cases:15.71%
controls:3.80%
cases:22.47%
controls:19.26%
cases:30.77%
controls:30.43%
47
445
144
1456
42
341
149
1560
11
78
180
1823
9
5
182
1896
30
72
161
1822
40
348
138
1459
44
434
99
992
Laboratory Visit
OMOP4822461 [32036]
-9.0e-02
1.8e-01
3.7e-01
3.5e+00
8.7e-01
2.5e-01
1.2e-01
cases:34.55%
controls:36.61%
cases:38.74%
controls:34.51%
cases:15.71%
controls:11.36%
cases:22.51%
controls:0.89%
cases:24.08%
controls:11.72%
cases:41.01%
controls:35.20%
cases:47.55%
controls:44.67%
66
696
125
1205
74
656
117
1245
30
216
161
1685
43
17
148
1884
46
222
145
1672
73
636
105
1171
68
637
75
789
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-9.7e-02
2.7e-01
4.3e-01
3.0e+00
1.3e+00
3.6e-01
5.5e-02
cases:31.94%
controls:34.09%
cases:34.55%
controls:28.83%
cases:10.47%
controls:7.10%
cases:6.81%
controls:0.37%
cases:20.42%
controls:6.44%
cases:38.20%
controls:30.22%
cases:43.36%
controls:42.01%
61
648
130
1253
66
548
125
1353
20
135
171
1766
13
7
178
1894
39
122
152
1772
68
546
110
1261
62
599
81
827
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-9.7e-02
2.7e-01
4.3e-01
3.0e+00
1.3e+00
3.6e-01
6.1e-02
cases:31.94%
controls:34.09%
cases:34.55%
controls:28.77%
cases:10.47%
controls:7.10%
cases:6.81%
controls:0.37%
cases:20.42%
controls:6.49%
cases:38.20%
controls:30.16%
cases:43.36%
controls:41.87%
61
648
130
1253
66
547
125
1354
20
135
171
1766
13
7
178
1894
39
123
152
1771
68
545
110
1262
62
597
81
829
Platelets [#/volume] in Blood
26515-7 [3007461]
-9.7e-02
2.7e-01
4.3e-01
3.0e+00
1.3e+00
3.6e-01
6.1e-02
cases:31.94%
controls:34.09%
cases:34.55%
controls:28.83%
cases:10.47%
controls:7.10%
cases:6.81%
controls:0.37%
cases:20.42%
controls:6.49%
cases:38.20%
controls:30.22%
cases:43.36%
controls:41.87%
61
648
130
1253
66
548
125
1353
20
135
171
1766
13
7
178
1894
39
123
152
1771
68
546
110
1261
62
597
81
829
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-9.5e-02
2.7e-01
4.3e-01
3.0e+00
1.3e+00
3.6e-01
8.7e-02
cases:31.94%
controls:34.03%
cases:34.55%
controls:28.83%
cases:10.47%
controls:7.05%
cases:6.81%
controls:0.37%
cases:20.42%
controls:6.49%
cases:38.20%
controls:30.22%
cases:44.06%
controls:41.94%
61
647
130
1254
66
548
125
1353
20
134
171
1767
13
7
178
1894
39
123
152
1771
68
546
110
1261
63
598
80
828
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-9.7e-02
2.7e-01
4.3e-01
3.0e+00
1.3e+00
3.6e-01
5.8e-02
cases:31.94%
controls:34.09%
cases:34.55%
controls:28.83%
cases:10.47%
controls:7.10%
cases:6.81%
controls:0.37%
cases:20.42%
controls:6.49%
cases:38.20%
controls:30.22%
cases:43.36%
controls:41.94%
61
648
130
1253
66
548
125
1353
20
135
171
1766
13
7
178
1894
39
123
152
1771
68
546
110
1261
62
598
81
828
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-9.7e-02
2.7e-01
4.3e-01
3.0e+00
1.3e+00
3.6e-01
5.5e-02
cases:31.94%
controls:34.09%
cases:34.55%
controls:28.77%
cases:10.47%
controls:7.05%
cases:6.81%
controls:0.37%
cases:20.42%
controls:6.49%
cases:38.20%
controls:30.22%
cases:43.36%
controls:42.01%
61
648
130
1253
66
547
125
1354
20
134
171
1767
13
7
178
1894
39
123
152
1771
68
546
110
1261
62
599
81
827
MCH [Entitic mass]
28539-5 [3035941]
-9.5e-02
2.7e-01
4.3e-01
3.0e+00
1.3e+00
3.6e-01
5.8e-02
cases:31.94%
controls:34.03%
cases:34.55%
controls:28.77%
cases:10.47%
controls:7.05%
cases:6.81%
controls:0.37%
cases:20.42%
controls:6.49%
cases:38.20%
controls:30.22%
cases:43.36%
controls:41.94%
61
647
130
1254
66
547
125
1354
20
134
171
1767
13
7
178
1894
39
123
152
1771
68
546
110
1261
62
598
81
828
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-6.3e-02
2.7e-01
5.3e-01
2.9e+00
1.4e+00
3.7e-01
1.1e-01
cases:30.89%
controls:32.25%
cases:32.46%
controls:26.83%
cases:10.47%
controls:6.42%
cases:5.24%
controls:0.32%
cases:19.90%
controls:5.91%
cases:35.96%
controls:27.95%
cases:42.66%
controls:39.90%
59
613
132
1288
62
510
129
1391
20
122
171
1779
10
6
181
1895
38
112
153
1782
64
505
114
1302
61
569
82
857
Supplier / Service Provider
OMOP5117446 [33004]
-8.2e-01
-6.3e-01
—
—
—
2.0e+00
2.8e+00
cases:12.57%
controls:24.67%
cases:3.66%
controls:6.68%
—
—
—
—
—
—
cases:3.93%
controls:0.55%
cases:13.29%
controls:0.91%
24
469
167
1432
7
127
184
1774
—
—
—
7
10
171
1797
19
13
124
1413
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 [45552380]
2.0e+00
1.9e+00
—
—
—
2.0e+00
1.3e+00
cases:4.71%
controls:0.68%
cases:3.14%
controls:0.47%
—
—
—
—
—
—
cases:3.93%
controls:0.55%
cases:4.20%
controls:1.19%
9
13
182
1888
6
9
185
1892
—
—
—
7
10
171
1797
6
17
137
1409
Right side
ZXA00 [2001311346]
7.4e-01
1.6e+00
1.0e+50
1.0e+50
—
2.3e+00
3.3e-01
cases:6.28%
controls:3.10%
cases:4.71%
controls:0.95%
cases:5.24%
controls:0.00%
cases:4.71%
controls:0.00%
—
—
cases:7.87%
controls:0.83%
cases:5.59%
controls:4.07%
12
59
179
1842
9
18
182
1883
10
0
181
1901
9
0
182
1901
—
14
15
164
1792
8
58
135
1368
Office Visit
OMOP4822458 [581477]
7.9e-01
1.3e+00
—
—
—
1.8e+00
7.0e-01
cases:16.23%
controls:8.10%
cases:6.28%
controls:1.84%
—
—
—
—
—
—
cases:10.11%
controls:1.88%
cases:13.99%
controls:7.50%
31
154
160
1747
12
35
179
1866
—
—
—
18
34
160
1773
20
107
123
1319
Pharmacy visit
OMOP4822462 [581458]
2.4e-01
5.8e-01
7.9e-01
1.6e+00
1.3e+00
8.2e-01
1.3e-01
cases:93.19%
controls:91.53%
cases:90.05%
controls:83.48%
cases:70.68%
controls:52.18%
cases:13.09%
controls:2.84%
cases:79.58%
controls:50.48%
cases:92.13%
controls:83.73%
cases:93.01%
controls:92.15%
178
1740
13
161
172
1587
19
314
135
992
56
909
25
54
166
1847
152
956
39
938
164
1513
14
294
133
1314
10
112
Internal Medicine
11 [38004456]
6.1e-01
5.9e-01
9.3e-01
—
1.4e+00
8.3e-01
7.0e-01
cases:38.74%
controls:25.62%
cases:17.28%
controls:10.36%
cases:3.66%
controls:1.47%
—
—
cases:6.28%
controls:1.58%
cases:20.22%
controls:9.96%
cases:37.76%
controls:23.07%
74
487
117
1414
33
197
158
1704
7
28
184
1873
—
12
30
179
1864
36
180
142
1627
54
329
89
1097
One hour or less
ZXE00 [2001311394]
1.7e-01
1.4e+00
—
1.0e+50
—
2.1e+00
9.0e-01
cases:7.33%
controls:6.26%
cases:6.28%
controls:1.63%
—
—
cases:8.90%
controls:0.00%
—
—
cases:8.43%
controls:1.16%
cases:11.89%
controls:5.19%
14
119
177
1782
12
31
179
1870
—
17
0
174
1901
—
15
21
163
1786
17
74
126
1352
After-cataract
H26.4 [45600893]
—
—
—
—
—
1.9e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:6.18%
controls:1.00%
cases:8.39%
controls:1.96%
—
—
—
—
—
11
18
167
1789
12
28
131
1398
Inpatient Visit
IP [9201]
2.5e-01
7.6e-01
2.3e+00
1.0e+50
—
9.9e-01
4.4e-01
cases:10.47%
controls:8.36%
cases:6.81%
controls:3.31%
cases:4.71%
controls:0.47%
cases:13.09%
controls:0.00%
—
—
cases:8.99%
controls:3.54%
cases:11.19%
controls:7.50%
20
159
171
1742
13
63
178
1838
9
9
182
1892
25
0
166
1901
—
16
64
162
1743
16
107
127
1319
Basophils [#/volume] in Blood
26444-0 [3006315]
2.3e-01
2.9e-01
—
—
2.1e+00
1.2e+00
6.0e-01
cases:13.61%
controls:11.10%
cases:8.38%
controls:6.42%
—
—
—
—
cases:6.81%
controls:0.90%
cases:17.98%
controls:6.31%
cases:17.48%
controls:10.38%
26
211
165
1690
16
122
175
1779
—
—
13
17
178
1877
32
114
146
1693
25
148
118
1278
Emergency Medicine
93 [38004510]
3.8e-01
4.8e-01
1.6e+00
1.0e+50
1.6e+00
5.2e-01
1.7e-01
cases:19.37%
controls:14.10%
cases:10.99%
controls:7.10%
cases:4.71%
controls:1.00%
cases:5.24%
controls:0.00%
cases:4.19%
controls:0.84%
cases:12.92%
controls:8.14%
cases:19.58%
controls:17.04%
37
268
154
1633
21
135
170
1766
9
19
182
1882
10
0
181
1901
8
16
183
1878
23
147
155
1660
28
243
115
1183
Psychiatry
26 [38004469]
3.8e-01
1.2e+00
—
—
—
1.9e+00
1.3e+00
cases:4.71%
controls:3.26%
cases:3.66%
controls:1.16%
—
—
—
—
—
—
cases:6.74%
controls:1.05%
cases:9.79%
controls:2.95%
9
62
182
1839
7
22
184
1879
—
—
—
12
19
166
1788
14
42
129
1384
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.9e-01
2.9e-01
—
—
2.0e+00
1.2e+00
6.0e-01
cases:13.09%
controls:11.10%
cases:8.38%
controls:6.42%
—
—
—
—
cases:6.81%
controls:1.00%
cases:17.98%
controls:6.31%
cases:17.48%
controls:10.38%
25
211
166
1690
16
122
175
1779
—
—
13
19
178
1875
32
114
146
1693
25
148
118
1278
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.0e-01
2.1e-01
—
—
2.0e+00
1.1e+00
5.7e-01
cases:13.61%
controls:11.47%
cases:8.38%
controls:6.89%
—
—
—
—
cases:6.81%
controls:0.95%
cases:17.98%
controls:6.64%
cases:17.48%
controls:10.73%
26
218
165
1683
16
131
175
1770
—
—
13
18
178
1876
32
120
146
1687
25
153
118
1273
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
2.2e-01
2.7e-01
—
—
2.0e+00
1.2e+00
5.7e-01
cases:13.61%
controls:11.26%
cases:8.38%
controls:6.52%
—
—
—
—
cases:6.81%
controls:1.00%
cases:17.98%
controls:6.36%
cases:17.48%
controls:10.66%
26
214
165
1687
16
124
175
1777
—
—
13
19
178
1875
32
115
146
1692
25
152
118
1274
Thorax X-ray examination
GD1AA [2001303617]
1.9e-01
7.3e-01
1.4e+00
1.0e+50
1.9e+00
1.2e+00
6.2e-01
cases:10.47%
controls:8.78%
cases:7.33%
controls:3.68%
cases:2.62%
controls:0.63%
cases:3.14%
controls:0.00%
cases:3.66%
controls:0.58%
cases:10.11%
controls:3.27%
cases:16.78%
controls:9.75%
20
167
171
1734
14
70
177
1831
5
12
186
1889
6
0
185
1901
7
11
184
1883
18
59
160
1748
24
139
119
1287
Endocrinology
46 [38004485]
1.4e+00
1.1e+00
—
—
—
1.7e+00
9.4e-01
cases:10.47%
controls:2.79%
cases:5.24%
controls:1.74%
—
—
—
—
—
—
cases:8.43%
controls:1.72%
cases:7.69%
controls:3.16%
20
53
171
1848
10
33
181
1868
—
—
—
15
31
163
1776
11
45
132
1381
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.3e-01
2.4e-01
—
—
2.1e+00
9.8e-01
4.6e-01
cases:11.52%
controls:10.26%
cases:7.33%
controls:5.84%
—
—
—
—
cases:6.28%
controls:0.84%
cases:14.61%
controls:6.03%
cases:14.69%
controls:9.82%
22
195
169
1706
14
111
177
1790
—
—
12
16
179
1878
26
109
152
1698
21
140
122
1286
Cathetrisation of vein
TPH04 [2001309597]
1.1e+00
1.9e+00
—
1.0e+50
—
8.5e-01
2.3e-01
cases:8.38%
controls:2.95%
cases:4.19%
controls:0.63%
—
—
cases:3.14%
controls:0.00%
—
—
cases:2.81%
controls:1.22%
cases:4.20%
controls:3.37%
16
56
175
1845
8
12
183
1889
—
6
0
185
1901
—
5
22
173
1785
6
48
137
1378
Plain photography of ocular fundus
CK2S4 [2001301455]
1.6e+00
—
—
—
—
3.0e+00
—
cases:3.66%
controls:0.79%
—
—
—
—
—
—
—
—
cases:5.06%
controls:0.28%
—
—
7
15
184
1886
—
—
—
—
9
5
169
1802
—
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.8e-02
2.2e-01
—
—
2.0e+00
9.5e-01
4.2e-01
cases:10.99%
controls:10.63%
cases:7.33%
controls:6.00%
—
—
—
—
cases:6.28%
controls:0.90%
cases:14.61%
controls:6.20%
cases:14.69%
controls:10.17%
21
202
170
1699
14
114
177
1787
—
—
12
17
179
1877
26
112
152
1695
21
145
122
1281
Basophils/Leukocytes in Blood
30180-4 [3022096]
-5.3e-03
2.2e-01
—
—
2.0e+00
9.5e-01
4.3e-01
cases:10.47%
controls:10.52%
cases:7.33%
controls:6.00%
—
—
—
—
cases:6.28%
controls:0.90%
cases:14.61%
controls:6.20%
cases:14.69%
controls:10.10%
20
200
171
1701
14
114
177
1787
—
—
12
17
179
1877
26
112
152
1695
21
144
122
1282
Infectious Disease
44 [38004484]
—
1.5e+00
1.0e+50
—
1.0e+50
3.0e+00
1.1e+00
—
—
cases:3.14%
controls:0.68%
cases:2.62%
controls:0.00%
—
—
cases:2.62%
controls:0.00%
cases:7.87%
controls:0.44%
cases:6.29%
controls:2.10%
—
6
13
185
1888
5
0
186
1901
—
5
0
186
1894
14
8
164
1799
9
30
134
1396
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
6.9e-02
2.1e-01
—
—
1.9e+00
9.4e-01
3.8e-01
cases:11.52%
controls:10.84%
cases:7.33%
controls:6.05%
—
—
—
—
cases:6.28%
controls:0.95%
cases:14.61%
controls:6.25%
cases:14.69%
controls:10.52%
22
206
169
1695
14
115
177
1786
—
—
12
18
179
1876
26
113
152
1694
21
150
122
1276
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.3e-02
2.3e-01
—
—
1.9e+00
9.4e-01
4.3e-01
cases:10.99%
controls:10.68%
cases:7.33%
controls:5.89%
—
—
—
—
cases:6.28%
controls:0.95%
cases:14.61%
controls:6.25%
cases:14.69%
controls:10.10%
21
203
170
1698
14
112
177
1789
—
—
12
18
179
1876
26
113
152
1694
21
144
122
1282
pantoprazole; oral, parenteral
A02BC02 [21600097]
2.2e-01
7.3e-01
1.8e-01
—
2.0e+00
5.1e-01
3.9e-01
cases:20.42%
controls:17.10%
cases:17.80%
controls:9.47%
cases:3.14%
controls:2.63%
—
—
cases:16.23%
controls:2.53%
cases:15.17%
controls:9.74%
cases:26.57%
controls:19.71%
39
325
152
1576
34
180
157
1721
6
50
185
1851
—
31
48
160
1846
27
176
151
1631
38
281
105
1145
Conjunctival surface anesthesia
WX100 [2001310764]
—
—
—
1.0e+50
—
2.7e+00
—
—
—
—
—
—
—
cases:4.19%
controls:0.00%
—
—
cases:6.18%
controls:0.44%
—
—
—
—
—
8
0
183
1901
—
11
8
167
1799
—
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
—
—
—
—
1.0e+50
2.7e+00
—
—
—
—
—
—
—
—
—
cases:3.14%
controls:0.00%
cases:3.93%
controls:0.28%
—
—
—
—
—
—
6
0
185
1894
7
5
171
1802
—
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
—
—
—
—
1.0e+50
2.7e+00
—
—
—
—
—
—
—
—
—
cases:3.14%
controls:0.00%
cases:3.93%
controls:0.28%
—
—
—
—
—
—
6
0
185
1894
7
5
171
1802
—
Sedation and analgesia
WX002 [2001310758]
5.2e-01
2.0e+00
—
1.0e+50
—
2.6e+00
9.0e-01
cases:4.19%
controls:2.52%
cases:2.62%
controls:0.37%
—
—
cases:5.76%
controls:0.00%
—
—
cases:7.87%
controls:0.61%
cases:6.29%
controls:2.66%
8
48
183
1853
5
7
186
1894
—
11
0
180
1901
—
14
11
164
1796
9
38
134
1388
Parabulbar anesthesia
WX140 [2001310772]
2.6e+00
—
1.0e+50
1.0e+50
1.0e+50
—
1.9e+00
cases:4.19%
controls:0.32%
—
—
cases:4.19%
controls:0.00%
cases:13.09%
controls:0.00%
cases:4.71%
controls:0.00%
—
—
cases:4.20%
controls:0.63%
8
6
183
1895
—
8
0
183
1901
25
0
166
1901
9
0
182
1894
—
6
9
137
1417
Retinal detachment with retinal break
H33.0 [45547857]
2.6e+00
—
—
—
1.0e+50
1.0e+50
—
cases:4.19%
controls:0.32%
—
—
—
—
—
—
cases:4.19%
controls:0.00%
cases:10.67%
controls:0.00%
—
—
8
6
183
1895
—
—
—
8
0
183
1894
19
0
159
1807
—
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.4e-01
—
—
—
1.0e+50
2.6e+00
9.4e-01
cases:3.14%
controls:2.74%
—
—
—
—
—
—
cases:2.62%
controls:0.00%
cases:6.18%
controls:0.50%
cases:4.90%
controls:1.96%
6
52
185
1849
—
—
—
5
0
186
1894
11
9
167
1798
7
28
136
1398
General Practice
1 [38004446]
4.0e-01
5.7e-01
1.2e+00
—
1.6e+00
9.0e-01
4.0e-01
cases:20.94%
controls:15.10%
cases:10.99%
controls:6.52%
cases:3.14%
controls:0.95%
—
—
cases:4.71%
controls:0.95%
cases:15.17%
controls:6.81%
cases:25.17%
controls:18.44%
40
287
151
1614
21
124
170
1777
6
18
185
1883
—
9
18
182
1876
27
123
151
1684
36
263
107
1163
Day surgery
ZXD20 [2001311388]
—
—
1.0e+50
—
—
2.5e+00
1.6e+00
—
—
—
—
cases:2.62%
controls:0.00%
—
—
—
—
cases:3.37%
controls:0.28%
cases:5.59%
controls:1.19%
—
—
5
0
186
1901
—
—
6
5
172
1802
8
17
135
1409
Rheumatology
66 [38004491]
1.1e+00
9.1e-01
—
—
—
1.4e+00
6.2e-01
cases:8.90%
controls:3.16%
cases:4.19%
controls:1.74%
—
—
—
—
—
—
cases:7.30%
controls:1.94%
cases:5.59%
controls:3.09%
17
60
174
1841
8
33
183
1868
—
—
—
13
35
165
1772
8
44
135
1382
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.4e-01
2.1e-01
5.2e-01
—
1.6e+00
8.7e-01
7.0e-01
cases:14.14%
controls:12.52%
cases:8.90%
controls:7.36%
cases:3.14%
controls:1.89%
—
—
cases:7.85%
controls:1.69%
cases:15.73%
controls:7.25%
cases:21.68%
controls:12.06%
27
238
164
1663
17
140
174
1761
6
36
185
1865
—
15
32
176
1862
28
131
150
1676
31
172
112
1254
General anesthesia, balanced
WX408 [2001310808]
2.3e-01
—
—
1.0e+50
—
2.4e+00
1.1e+00
cases:4.19%
controls:3.37%
—
—
—
—
cases:2.62%
controls:0.00%
—
—
cases:3.93%
controls:0.39%
cases:6.99%
controls:2.38%
8
64
183
1837
—
—
5
0
186
1901
—
7
7
171
1800
10
34
133
1392
More than one and less than three hours
ZXE10 [2001311401]
2.4e-01
1.3e+00
—
1.0e+50
—
2.3e+00
6.0e-01
cases:6.28%
controls:5.00%
cases:4.71%
controls:1.32%
—
—
cases:3.66%
controls:0.00%
—
—
cases:9.55%
controls:1.00%
cases:8.39%
controls:4.77%
12
95
179
1806
9
25
182
1876
—
7
0
184
1901
—
17
18
161
1789
12
68
131
1358
Intravenous general anesthesia
WX404 [2001310807]
—
—
—
—
—
2.3e+00
8.4e-01
—
—
—
—
—
—
—
—
—
—
cases:2.81%
controls:0.28%
cases:3.50%
controls:1.54%
—
—
—
—
—
5
5
173
1802
5
22
138
1404
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.81%
controls:0.28%
—
—
—
—
—
—
—
5
5
173
1802
—
Laser discission of secondary cataract
CJB10 [2001301313]
6.2e-01
—
—
—
—
2.3e+00
1.4e+00
cases:2.62%
controls:1.42%
—
—
—
—
—
—
—
—
cases:6.18%
controls:0.66%
cases:4.90%
controls:1.19%
5
27
186
1874
—
—
—
—
11
12
167
1795
7
17
136
1409
nepafenac
S01BC10 [21603648]
1.0e+00
1.7e+00
—
—
—
2.2e+00
9.9e-01
cases:4.19%
controls:1.53%
cases:2.62%
controls:0.47%
—
—
—
—
—
—
cases:4.49%
controls:0.50%
cases:3.50%
controls:1.33%
8
29
183
1872
5
9
186
1892
—
—
—
8
9
170
1798
5
19
138
1407
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
cases:3.93%
controls:0.44%
—
—
—
—
—
—
—
7
8
171
1799
—
Scheduled procedure
ZXD10 [2001311387]
-6.1e-02
1.1e+00
1.0e+50
—
—
2.2e+00
6.8e-01
cases:5.76%
controls:6.10%
cases:4.71%
controls:1.68%
cases:6.28%
controls:0.00%
—
—
—
—
cases:9.55%
controls:1.16%
cases:9.09%
controls:4.84%
11
116
180
1785
9
32
182
1869
12
0
179
1901
—
—
17
21
161
1786
13
69
130
1357
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
2.2e+00
—
—
—
—
—
—
cases:3.14%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
185
1894
—
—
—
—
—
—
Bacteria identified in Blood by Culture
600-7 [3023368]
6.3e-01
1.2e+00
2.2e+00
—
—
4.6e-01
4.2e-01
cases:8.38%
controls:4.63%
cases:4.71%
controls:1.53%
cases:3.14%
controls:0.37%
—
—
—
—
cases:3.37%
controls:2.16%
cases:8.39%
controls:5.68%
16
88
175
1813
9
29
182
1872
6
7
185
1894
—
—
6
39
172
1768
12
81
131
1345
Short blood count panel - Blood
55429-5 [40758558]
9.2e-02
6.5e-01
—
—
2.2e+00
3.9e-01
6.8e-01
cases:4.71%
controls:4.31%
cases:3.66%
controls:1.95%
—
—
—
—
cases:3.14%
controls:0.37%
cases:4.49%
controls:3.10%
cases:10.49%
controls:5.61%
9
82
182
1819
7
37
184
1864
—
—
6
7
185
1887
8
56
170
1751
15
80
128
1346
hypromellose
S01KA02 [21605115]
5.8e-01
1.1e+00
—
—
-1.0e+50
2.1e+00
8.3e-01
cases:4.71%
controls:2.68%
cases:2.62%
controls:0.89%
—
—
—
—
cases:0.00%
controls:0.32%
cases:5.06%
controls:0.66%
cases:5.59%
controls:2.52%
9
51
182
1850
5
17
186
1884
—
—
0
6
191
1888
9
12
169
1795
8
36
135
1390
fluorometholone
S01BA07 [21603624]
-1.0e+50
-1.0e+50
—
—
—
—
2.0e+00
cases:0.00%
controls:0.79%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
cases:4.20%
controls:0.56%
0
15
191
1886
0
6
191
1895
—
—
—
—
6
8
137
1418
Kuhnt-Junius degeneration
H35.30 [2000502314]
1.0e+00
2.0e+00
—
—
—
—
1.6e+00
cases:3.66%
controls:1.32%
cases:4.19%
controls:0.58%
—
—
—
—
—
—
—
—
cases:5.59%
controls:1.19%
7
25
184
1876
8
11
183
1890
—
—
—
—
8
17
135
1409
Dry eye syndrome
H04.10 [2000502254]
—
—
—
—
—
2.0e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:3.93%
controls:0.55%
cases:5.59%
controls:1.54%
—
—
—
—
—
7
10
171
1797
8
22
135
1404
Differential panel, method unspecified - Blood
69738-3 [42870588]
-2.0e-01
7.6e-02
—
—
2.0e+00
6.7e-01
-1.1e-01
cases:6.28%
controls:7.57%
cases:4.19%
controls:3.89%
—
—
—
—
cases:4.71%
controls:0.69%
cases:8.43%
controls:4.48%
cases:6.29%
controls:6.94%
12
144
179
1757
8
74
183
1827
—
—
9
13
182
1881
15
81
163
1726
9
99
134
1327
Telephone prescription or other care instructions
WZB00 [2001310884]
6.5e-01
—
—
—
—
1.9e+00
—
cases:6.28%
controls:3.37%
—
—
—
—
—
—
—
—
cases:4.49%
controls:0.66%
—
—
12
64
179
1837
—
—
—
—
8
12
170
1795
—
Carpal tunnel syndrome
G56.0 [45566891]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.29%
controls:0.98%
—
—
—
—
—
—
9
14
134
1412
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
1.9e+00
-1.0e+50
—
—
—
—
—
cases:3.66%
controls:0.58%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
7
11
184
1890
0
7
191
1894
—
—
—
—
—
Perimetry
XCK00 [2001301380]
1.9e+00
—
—
—
—
—
1.5e+00
cases:3.66%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:4.90%
controls:1.12%
7
11
184
1890
—
—
—
—
—
7
16
136
1410
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.4e-01
5.1e-01
—
—
1.8e+00
8.4e-01
4.6e-01
cases:11.52%
controls:9.31%
cases:7.33%
controls:4.52%
—
—
—
—
cases:4.19%
controls:0.69%
cases:10.11%
controls:4.65%
cases:16.08%
controls:10.80%
22
177
169
1724
14
86
177
1815
—
—
8
13
183
1881
18
84
160
1723
23
154
120
1272
Cathetrisation of artery
TPH07 [2001309747]
1.8e+00
—
—
—
—
—
9.3e-01
cases:5.24%
controls:0.89%
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.40%
10
17
181
1884
—
—
—
—
—
5
20
138
1406
Physiotherapist
Z3226 [2001311560]
—
—
—
—
—
1.8e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:3.93%
controls:0.66%
cases:6.99%
controls:2.24%
—
—
—
—
—
7
12
171
1795
10
32
133
1394
dexamethasone; oral, parenteral
H02AB02 [21602730]
6.8e-01
1.7e+00
—
—
—
1.4e+00
5.5e-01
cases:3.66%
controls:1.89%
cases:4.71%
controls:0.89%
—
—
—
—
—
—
cases:3.37%
controls:0.83%
cases:4.20%
controls:2.45%
7
36
184
1865
9
17
182
1884
—
—
—
6
15
172
1792
6
35
137
1391
12 lead EKG panel
34534-8 [3044889]
3.1e-01
3.8e-01
—
—
1.7e+00
1.1e-01
1.4e-02
cases:21.47%
controls:16.68%
cases:12.57%
controls:8.94%
—
—
—
—
cases:4.71%
controls:0.90%
cases:9.55%
controls:8.63%
cases:20.28%
controls:20.06%
41
317
150
1584
24
170
167
1731
—
—
9
17
182
1877
17
156
161
1651
29
286
114
1140
brinzolamide, combinations
S01EC54 [45893490]
9.3e-01
1.2e+00
—
—
—
1.7e+00
1.4e+00
cases:2.62%
controls:1.05%
cases:3.66%
controls:1.16%
—
—
—
—
—
—
cases:5.06%
controls:1.00%
cases:4.90%
controls:1.26%
5
20
186
1881
7
22
184
1879
—
—
—
9
18
169
1789
7
18
136
1408
Medical doctor
Z2221 [2001311556]
-2.4e-01
8.1e-01
—
—
—
1.6e+00
8.8e-01
cases:3.14%
controls:3.95%
cases:3.14%
controls:1.42%
—
—
—
—
—
—
cases:6.74%
controls:1.44%
cases:11.19%
controls:4.98%
6
75
185
1826
6
27
185
1874
—
—
—
12
26
166
1781
16
71
127
1355
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.6e+00
—
—
—
—
1.2e+00
8.2e-01
cases:5.24%
controls:1.10%
—
—
—
—
—
—
—
—
cases:2.81%
controls:0.83%
cases:4.20%
controls:1.89%
10
21
181
1880
—
—
—
—
5
15
173
1792
6
27
137
1399
Gastroenterology
10 [38004455]
5.0e-01
1.6e+00
—
—
—
9.9e-01
8.9e-01
cases:7.85%
controls:4.89%
cases:6.28%
controls:1.37%
—
—
—
—
—
—
cases:4.49%
controls:1.72%
cases:9.79%
controls:4.28%
15
93
176
1808
12
26
179
1875
—
—
—
8
31
170
1776
14
61
129
1365
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 [21600727]
1.4e+00
—
—
—
—
—
—
cases:5.76%
controls:1.47%
—
—
—
—
—
—
—
—
—
—
—
—
11
28
180
1873
—
—
—
—
—
—
Blasts/Leukocytes in Blood
26446-5 [3025159]
7.1e-01
—
—
—
—
1.4e+00
7.5e-01
cases:3.66%
controls:1.84%
—
—
—
—
—
—
—
—
cases:5.62%
controls:1.44%
cases:3.50%
controls:1.68%
7
35
184
1866
—
—
—
—
10
26
168
1781
5
24
138
1402
CBC panel - Blood by Automated count
58410-2 [40761511]
-1.1e-01
3.1e-01
5.2e-01
—
1.4e+00
2.8e-01
7.0e-02
cases:27.23%
controls:29.51%
cases:24.61%
controls:19.31%
cases:6.81%
controls:4.16%
—
—
cases:13.61%
controls:3.85%
cases:23.03%
controls:18.48%
cases:34.97%
controls:33.38%
52
561
139
1340
47
367
144
1534
13
79
178
1822
—
26
73
165
1821
41
334
137
1473
50
476
93
950
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.4e+00
1.2e+00
—
—
—
1.2e+00
9.3e-01
cases:6.28%
controls:1.68%
cases:3.66%
controls:1.10%
—
—
—
—
—
—
cases:3.93%
controls:1.22%
cases:6.99%
controls:2.88%
12
32
179
1869
7
21
184
1880
—
—
—
7
22
171
1785
10
41
133
1385
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
3.0e-01
3.2e-01
—
—
—
1.4e+00
5.9e-01
cases:6.81%
controls:5.16%
cases:3.66%
controls:2.68%
—
—
—
—
—
—
cases:8.43%
controls:2.32%
cases:8.39%
controls:4.84%
13
98
178
1803
7
51
184
1850
—
—
—
15
42
163
1765
12
69
131
1357
clindamycin; oral, parenteral
J01FF01 [21602985]
1.3e+00
—
—
—
—
—
4.9e-01
cases:8.90%
controls:2.58%
—
—
—
—
—
—
—
—
—
—
cases:5.59%
controls:3.51%
17
49
174
1852
—
—
—
—
—
8
50
135
1376
insulin aspart; parenteral
A10AB05 [21600719]
1.0e+00
1.1e+00
—
—
1.1e+00
1.2e+00
7.1e-01
cases:6.28%
controls:2.31%
cases:6.81%
controls:2.42%
—
—
—
—
cases:2.62%
controls:0.90%
cases:7.87%
controls:2.43%
cases:7.69%
controls:3.93%
12
44
179
1857
13
46
178
1855
—
—
5
17
186
1877
14
44
164
1763
11
56
132
1370
insulin aspart; parenteral
A10AD05 [21600733]
1.0e+00
1.1e+00
—
—
1.1e+00
1.2e+00
7.1e-01
cases:6.28%
controls:2.37%
cases:6.81%
controls:2.47%
—
—
—
—
cases:2.62%
controls:0.90%
cases:7.87%
controls:2.49%
cases:7.69%
controls:3.93%
12
45
179
1856
13
47
178
1854
—
—
5
17
186
1877
14
45
164
1762
11
56
132
1370
insulin (human); parenteral
A10AD01 [21600729]
1.2e+00
4.5e-01
—
—
—
—
1.2e+00
cases:7.85%
controls:2.58%
cases:2.62%
controls:1.68%
—
—
—
—
—
—
—
—
cases:4.20%
controls:1.33%
15
49
176
1852
5
32
186
1869
—
—
—
—
6
19
137
1407
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-3.8e-02
3.9e-01
4.8e-01
—
1.4e+00
1.1e+00
2.7e-01
cases:17.80%
controls:18.36%
cases:13.09%
controls:9.26%
cases:2.62%
controls:1.63%
—
—
cases:4.19%
controls:1.11%
cases:21.91%
controls:8.19%
cases:23.78%
controls:19.28%
34
349
157
1552
25
176
166
1725
5
31
186
1870
—
8
21
183
1873
39
148
139
1659
34
275
109
1151
trimethoprim; oral, parenteral
J01EA01 [21602931]
3.8e-01
1.1e+00
-1.0e+50
—
—
3.2e-01
2.9e-01
cases:9.95%
controls:7.00%
cases:7.85%
controls:2.68%
cases:0.00%
controls:0.42%
—
—
—
—
cases:3.93%
controls:2.88%
cases:7.69%
controls:5.89%
19
133
172
1768
15
51
176
1850
0
8
191
1893
—
—
7
52
171
1755
11
84
132
1342
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
7.7e-02
3.2e-01
7.4e-01
—
1.1e+00
5.4e-01
1.7e-01
cases:24.61%
controls:23.20%
cases:23.56%
controls:18.31%
cases:8.90%
controls:4.47%
—
—
cases:12.04%
controls:4.38%
cases:28.65%
controls:18.98%
cases:30.07%
controls:26.65%
47
441
144
1460
45
348
146
1553
17
85
174
1816
—
23
83
168
1811
51
343
127
1464
43
380
100
1046
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
1.4e-01
3.4e-01
-1.0e+50
—
—
7.6e-01
1.1e+00
cases:8.90%
controls:7.84%
cases:3.14%
controls:2.26%
cases:0.00%
controls:0.32%
—
—
—
—
cases:4.49%
controls:2.16%
cases:17.48%
controls:6.66%
17
149
174
1752
6
43
185
1858
0
6
191
1895
—
—
8
39
170
1768
25
95
118
1331
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.2e-01
1.1e+00
1.1e+00
—
1.5e+00
8.1e-01
7.0e-01
cases:9.95%
controls:8.89%
cases:10.99%
controls:4.00%
cases:2.62%
controls:0.89%
—
—
cases:3.66%
controls:0.84%
cases:8.99%
controls:4.21%
cases:19.58%
controls:10.80%
19
169
172
1732
21
76
170
1825
5
17
186
1884
—
7
16
184
1878
16
76
162
1731
28
154
115
1272
Emergency Room and Inpatient Visit
ERIP [262]
6.2e-01
1.1e+00
—
1.0e+50
1.6e+00
3.3e-01
2.9e-01
cases:10.99%
controls:6.26%
cases:7.85%
controls:2.84%
—
—
cases:10.47%
controls:0.00%
cases:3.14%
controls:0.63%
cases:5.62%
controls:4.10%
cases:10.49%
controls:8.06%
21
119
170
1782
15
54
176
1847
—
20
0
171
1901
6
12
185
1882
10
74
168
1733
15
115
128
1311
Urgent procedure
ZXD05 [2001311386]
1.0e+00
1.5e+00
—
1.0e+50
—
1.1e+00
9.4e-02
cases:9.95%
controls:3.79%
cases:3.14%
controls:0.74%
—
—
cases:16.23%
controls:0.00%
—
—
cases:2.81%
controls:0.94%
cases:5.59%
controls:5.12%
19
72
172
1829
6
14
185
1887
—
31
0
160
1901
—
5
17
173
1790
8
73
135
1353
pH of Serum or Plasma
2753-2 [3018418]
1.5e-01
4.6e-01
—
—
1.6e+00
1.0e+00
2.4e-01
cases:7.85%
controls:6.84%
cases:5.24%
controls:3.37%
—
—
—
—
cases:2.62%
controls:0.53%
cases:8.43%
controls:3.21%
cases:9.79%
controls:7.85%
15
130
176
1771
10
64
181
1837
—
—
5
10
186
1884
15
58
163
1749
14
112
129
1314
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
-2.4e-01
1.7e-01
5.2e-01
—
9.7e-01
3.4e-01
2.5e-01
cases:19.90%
controls:23.99%
cases:22.51%
controls:19.62%
cases:7.85%
controls:4.84%
—
—
cases:10.99%
controls:4.49%
cases:26.97%
controls:20.75%
cases:32.87%
controls:27.56%
38
456
153
1445
43
373
148
1528
15
92
176
1809
—
21
85
170
1809
48
375
130
1432
47
393
96
1033
esomeprazole; oral, parenteral
A02BC05 [21600100]
5.3e-01
5.2e-01
—
—
1.3e+00
9.6e-01
4.6e-01
cases:13.09%
controls:8.15%
cases:7.33%
controls:4.47%
—
—
—
—
cases:4.71%
controls:1.32%
cases:9.55%
controls:3.87%
cases:11.89%
controls:7.85%
25
155
166
1746
14
85
177
1816
—
—
9
25
182
1869
17
70
161
1737
17
112
126
1314
Bacteria identified in Urine by Culture
630-4 [3026008]
4.6e-01
9.5e-01
—
—
—
8.1e-01
1.3e-01
cases:11.52%
controls:7.63%
cases:8.90%
controls:3.63%
—
—
—
—
—
—
cases:7.30%
controls:3.38%
cases:9.79%
controls:8.70%
22
145
169
1756
17
69
174
1832
—
—
—
13
61
165
1746
14
124
129
1302
Chest pain, unspecified
R07.4 [45558450]
9.5e-01
—
—
—
—
—
7.9e-02
cases:9.95%
controls:4.10%
—
—
—
—
—
—
—
—
—
—
cases:5.59%
controls:5.19%
19
78
172
1823
—
—
—
—
—
8
74
135
1352
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
8.7e-02
6.0e-01
—
—
1.4e+00
9.0e-01
3.7e-01
cases:12.04%
controls:11.15%
cases:9.95%
controls:5.73%
—
—
—
—
cases:4.71%
controls:1.16%
cases:12.36%
controls:5.42%
cases:16.78%
controls:12.27%
23
212
168
1689
19
109
172
1792
—
—
9
22
182
1872
22
98
156
1709
24
175
119
1251
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.0e-01
6.0e-01
8.1e-01
—
1.1e+00
8.8e-01
5.2e-01
cases:12.57%
controls:10.52%
cases:14.14%
controls:8.31%
cases:4.71%
controls:2.16%
—
—
cases:5.76%
controls:2.06%
cases:17.98%
controls:8.30%
cases:16.08%
controls:10.24%
24
200
167
1701
27
158
164
1743
9
41
182
1860
—
11
39
180
1855
32
150
146
1657
23
146
120
1280
Orthopedic Surgery
20 [38004465]
1.9e-01
5.9e-01
1.7e+00
—
—
4.2e-01
7.6e-01
cases:17.80%
controls:15.20%
cases:10.47%
controls:6.10%
cases:3.14%
controls:0.58%
—
—
—
—
cases:7.87%
controls:5.31%
cases:27.27%
controls:14.94%
34
289
157
1612
20
116
171
1785
6
11
185
1890
—
—
14
96
164
1711
39
213
104
1213
cefalexin; oral
J01DB01 [21602870]
6.1e-01
7.0e-01
—
—
—
5.7e-01
3.7e-01
cases:41.36%
controls:27.77%
cases:14.66%
controls:7.84%
—
—
—
—
—
—
cases:14.04%
controls:8.47%
cases:34.97%
controls:27.14%
79
528
112
1373
28
149
163
1752
—
—
—
25
153
153
1654
50
387
93
1039
Exposure to other specified factors
X58 [45756411]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1895
—
—
—
—
—
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
—
0
7
178
1800
—
celecoxib
L01XX33 [21603805]
—
-1.0e+50
—
—
—
—
8.8e-01
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.47%
—
0
9
191
1892
—
—
—
—
5
21
138
1405
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
—
—
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
cases:0.00%
controls:1.40%
—
—
—
—
0
5
191
1889
—
0
20
143
1406
Disease/condition unspecnature/site
A99 [2002000232]
—
-1.0e+50
—
—
—
—
9.9e-01
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.33%
—
0
5
191
1896
—
—
—
—
5
19
138
1407
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.1e-01
—
—
—
—
—
4.9e-01
cases:4.19%
controls:2.10%
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:2.17%
8
40
183
1861
—
—
—
—
—
5
31
138
1395
Anaemia other/unspecified
B82 [2002000293]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
0
5
191
1896
—
—
—
0
5
178
1802
—
Two-surface restoration
SFA20 [2001310359]
2.6e-01
3.0e-01
-1.0e+50
—
—
1.6e-01
1.4e-01
cases:14.66%
controls:11.73%
cases:6.81%
controls:5.16%
cases:0.00%
controls:0.68%
—
—
—
—
cases:6.18%
controls:5.31%
cases:17.48%
controls:15.50%
28
223
163
1678
13
98
178
1803
0
13
191
1888
—
—
11
96
167
1711
25
221
118
1205
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
4.7e-01
8.5e-01
—
—
—
-5.1e-02
1.6e-01
cases:12.57%
controls:8.26%
cases:6.28%
controls:2.79%
—
—
—
—
—
—
cases:3.37%
controls:3.54%
cases:10.49%
controls:9.05%
24
157
167
1744
12
53
179
1848
—
—
—
6
64
172
1743
15
129
128
1297
chlorhexidine
S03AA04 [21605193]
—
—
—
—
—
—
9.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.33%
—
—
—
—
—
—
5
19
138
1407
Urticaria, unspecified
L50.9 [45562541]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
—
Blood transfusion
WW500 [2001310603]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
0
5
191
1896
—
—
—
—
0
10
143
1416
Memory disturbance
P20 [2002000816]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
—
2.7e-01
cases:0.00%
controls:2.16%
cases:0.00%
controls:0.74%
—
—
—
—
cases:0.00%
controls:0.32%
—
—
cases:4.90%
controls:3.79%
0
41
191
1860
0
14
191
1887
—
—
0
6
191
1888
—
7
54
136
1372
Limited function/disability (R)
R28 [2002000897]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
5
143
1421
diclofenac, combinations; oral
M01AB55 [21603959]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
0
6
143
1420
Eye discharge
F03 [2002000401]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
0
7
143
1419
Excessive ear wax
H81 [2002000536]
—
—
—
—
—
—
2.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:2.66%
—
—
—
—
—
—
5
38
138
1388
Pneumonia, unspecified
J18.9 [45601123]
2.7e-01
—
—
—
—
4.4e-01
4.7e-01
cases:5.24%
controls:4.05%
—
—
—
—
—
—
—
—
cases:2.81%
controls:1.83%
cases:9.09%
controls:5.89%
10
77
181
1824
—
—
—
—
5
33
173
1774
13
84
130
1342
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 [3001784]
3.1e-02
1.6e-02
—
—
-1.0e+50
2.8e-01
-4.1e-01
cases:4.71%
controls:4.58%
cases:2.62%
controls:2.58%
—
—
—
—
cases:0.00%
controls:0.53%
cases:3.93%
controls:2.99%
cases:4.90%
controls:7.22%
9
87
182
1814
5
49
186
1852
—
—
0
10
191
1884
7
54
171
1753
7
103
136
1323
Insect bite/sting
S12 [2002000977]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
Cough
R05 [2002000886]
4.2e-01
—
—
—
—
—
—
cases:4.19%
controls:2.79%
—
—
—
—
—
—
—
—
—
—
—
—
8
53
183
1848
—
—
—
—
—
—
Delivery by elective caesarean section
O82.0 [45548833]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
H40.10 [2000502332]
—
—
—
—
—
1.4e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:3.37%
controls:0.89%
cases:3.50%
controls:0.70%
—
—
—
—
—
6
16
172
1791
5
10
138
1416
Upper gastrointestinal surgery
106 [44777669]
-2.4e-02
5.6e-01
—
—
—
1.7e-01
3.9e-01
cases:8.90%
controls:9.10%
cases:5.24%
controls:3.05%
—
—
—
—
—
—
cases:4.49%
controls:3.82%
cases:13.99%
controls:9.96%
17
173
174
1728
10
58
181
1843
—
—
—
8
69
170
1738
20
142
123
1284
Feeling depressed
P03 [2002000800]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
Monitoring the use of the aid
R5140 [2001310249]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
Rosacea
L71 [45586779]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
—
Tinea unguium
B35.1 [45590850]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.53%
—
—
—
—
—
—
cases:0.00%
controls:0.44%
—
—
—
0
10
191
1891
—
—
—
0
8
178
1799
—
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
2.8e-01
5.1e-01
—
—
—
4.0e-01
-3.4e-01
cases:5.24%
controls:4.00%
cases:5.24%
controls:3.21%
—
—
—
—
—
—
cases:5.06%
controls:3.43%
cases:4.90%
controls:6.73%
10
76
181
1825
10
61
181
1840
—
—
—
9
62
169
1745
7
96
136
1330
Other blockage of nerve
WX290 [2001310792]
-2.3e-02
9.3e-01
—
—
—
—
2.1e-01
cases:6.28%
controls:6.42%
cases:3.66%
controls:1.47%
—
—
—
—
—
—
—
—
cases:9.09%
controls:7.50%
12
122
179
1779
7
28
184
1873
—
—
—
—
13
107
130
1319
Nutritional therapy
R4190 [2001310243]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
ibuprofen
R02AX02 [1588667]
2.6e-01
2.5e-01
6.4e-01
—
5.5e-01
2.5e-01
1.3e-01
cases:33.51%
controls:27.99%
cases:15.18%
controls:12.20%
cases:3.14%
controls:1.68%
—
—
cases:2.62%
controls:1.53%
cases:15.17%
controls:12.23%
cases:30.07%
controls:27.42%
64
532
127
1369
29
232
162
1669
6
32
185
1869
—
5
29
186
1865
27
221
151
1586
43
391
100
1035
Cellulitis of finger and toe
L03.0 [45557691]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
0
6
178
1801
—
Cerebral infarction due to thrombosis of cerebral arteries
I63.3 [45562366]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.68%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.49%
0
13
191
1888
0
5
191
1896
—
—
—
—
0
7
143
1419
lidocaine; parenteral
C01BB01 [21600260]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1895
—
—
—
—
—
—
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
2.0e+00
—
—
—
—
—
—
cases:2.62%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
5
7
186
1894
—
—
—
—
—
—
Oedema, unspecified
R60.9 [45568143]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
5
178
1802
—
Occupatioal Medicine
901 [44777713]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
191
1893
—
—
—
—
—
—
Other function in accordance with physical therapy nomenclature
SPAT1295 [2001700396]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
cases:0.00%
controls:0.42%
—
—
—
—
—
0
6
178
1801
0
6
143
1420
Root filling of tooth with one root canal
SGB10 [2001310388]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
5
178
1802
—
Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
S83.5 [45608523]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1895
—
—
—
—
—
—
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
2.7e-01
1.5e-01
—
—
—
6.3e-01
-1.9e-01
cases:7.85%
controls:6.10%
cases:2.62%
controls:2.26%
—
—
—
—
—
—
cases:4.49%
controls:2.43%
cases:5.59%
controls:6.66%
15
116
176
1785
5
43
186
1858
—
—
—
8
44
170
1763
8
95
135
1331
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
-1.3e-01
2.0e-01
—
—
3.3e-01
7.6e-02
1.1e-01
cases:25.65%
controls:28.30%
cases:20.42%
controls:17.36%
—
—
—
—
cases:2.62%
controls:1.90%
cases:19.66%
controls:18.48%
cases:35.66%
controls:33.10%
49
538
142
1363
39
330
152
1571
—
—
5
36
186
1858
35
334
143
1473
51
472
92
954
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
7.0e-01
—
—
—
—
—
—
cases:3.14%
controls:1.58%
—
—
—
—
—
—
—
—
—
—
—
—
6
30
185
1871
—
—
—
—
—
—
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
C50.21 [2000500994]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
191
1893
—
—
—
—
—
—
Other obesity
E66.8 [45533036]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
191
1890
—
—
—
—
—
—
Chronic gingivitis
K05.1 [45605912]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
0
7
143
1419
Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
32046-5 [3021584]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
—
mometasone; nasal
R01AD09 [21605051]
-6.3e-01
—
-1.0e+50
—
—
—
2.7e-02
cases:4.71%
controls:8.47%
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
cases:7.69%
controls:7.50%
9
161
182
1740
—
0
9
191
1892
—
—
—
11
107
132
1319
Dislocation of shoulder joint
S43.0 [45573622]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
0
7
143
1419
furosemide; oral, parenteral
C03CA01 [21601518]
3.8e-01
5.0e-01
3.6e-01
—
7.7e-02
4.0e-01
4.7e-01
cases:13.61%
controls:9.73%
cases:13.09%
controls:8.36%
cases:4.19%
controls:2.95%
—
—
cases:2.62%
controls:2.43%
cases:14.04%
controls:9.85%
cases:19.58%
controls:13.25%
26
185
165
1716
25
159
166
1742
8
56
183
1845
—
5
46
186
1848
25
178
153
1629
28
189
115
1237
Cerebral infarction due to embolism of cerebral arteries
I63.4 [45591475]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
8
143
1418
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
3.8e-01
—
—
1.0e+50
—
—
—
cases:3.66%
controls:2.52%
—
—
—
—
cases:3.14%
controls:0.00%
—
—
—
—
—
—
7
48
184
1853
—
—
6
0
185
1901
—
—
—
Localized swelling, mass and lump, neck
R22.1 [45592412]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
0
6
143
1420
Pelvis X-ray examination
NE1AA [2001307792]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
0
6
191
1895
—
—
—
0
7
178
1800
—
Preventive oral health care, short
SCA01 [2001310302]
6.2e-01
—
—
—
—
—
3.0e-01
cases:5.24%
controls:2.89%
—
—
—
—
—
—
—
—
—
—
cases:4.20%
controls:3.16%
10
55
181
1846
—
—
—
—
—
6
45
137
1381
Cardiovascular disease other
K99 [2002000624]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
191
1892
—
—
—
—
—
—
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
96559-0 [36032269]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
Sprain and strain of other and unspecified parts of knee
S83.6 [45579536]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
5
178
1802
—
Recording of ECG
SPAT1097 [2001700198]
1.6e-01
—
—
—
—
-1.0e+50
3.6e-01
cases:3.14%
controls:2.68%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.44%
cases:3.50%
controls:2.45%
6
51
185
1850
—
—
—
—
0
8
178
1799
5
35
138
1391
androstanolone
A14AA01 [21600917]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
5
143
1421
Other primary gonarthrosis
M17.1 [45596493]
2.8e-01
7.0e-01
—
—
-1.0e+50
1.2e+00
7.9e-01
cases:5.24%
controls:4.00%
cases:2.62%
controls:1.32%
—
—
—
—
cases:0.00%
controls:0.48%
cases:3.37%
controls:1.00%
cases:6.29%
controls:2.95%
10
76
181
1825
5
25
186
1876
—
—
0
9
191
1885
6
18
172
1789
9
42
134
1384
Supervision of other normal pregnancy
Z34.8 [45537628]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
0
5
191
1896
—
—
—
0
6
178
1801
—
Rectal ultrasound examination of prostate
KE1BE [2001306106]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
0
5
191
1896
—
—
—
0
5
178
1802
—
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
FNA01 [2001303015]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
—
—
—
—
—
—
0
15
191
1886
—
—
—
—
—
—
dexamethasone
S01CB01 [21603664]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
5
178
1802
—
Malaise and fatigue
R53 [45553741]
7.2e-02
8.3e-01
—
—
—
1.2e+00
2.5e-01
cases:3.66%
controls:3.42%
cases:2.62%
controls:1.16%
—
—
—
—
—
—
cases:3.37%
controls:1.00%
cases:5.59%
controls:4.42%
7
65
184
1836
5
22
186
1879
—
—
—
6
18
172
1789
8
63
135
1363
Other specified pulpit
K04.08 [2000502703]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
5
178
1802
—
Fibromyalgia
M79.7 [45553272]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
10
143
1416
brompheniramine, combinations
R06AB51 [21603466]
2.9e-01
—
—
—
—
—
—
cases:3.14%
controls:2.37%
—
—
—
—
—
—
—
—
—
—
—
—
6
45
185
1856
—
—
—
—
—
—
Other health check-up
SPAT1370 [2001700471]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
0
7
143
1419
captopril; oral
C09AA01 [21601785]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
0
7
191
1894
—
—
—
0
6
178
1801
—
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
2.1e-01
8.8e-01
—
—
—
—
-3.3e-01
cases:5.76%
controls:4.73%
cases:2.62%
controls:1.10%
—
—
—
—
—
—
—
—
cases:4.20%
controls:5.75%
11
90
180
1811
5
21
186
1880
—
—
—
—
6
82
137
1344
False labour before 37 completed weeks of gestation
O47.0 [45582556]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
191
1892
—
—
—
—
—
—
Hyperplasia of prostate
N40 [45563015]
—
—
—
—
—
—
-2.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:4.49%
—
—
—
—
—
—
5
64
138
1362
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
8.8e-01
-1.0e+50
—
—
—
—
—
cases:2.62%
controls:1.10%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
5
21
186
1880
0
6
191
1895
—
—
—
—
—
piroxicam; ointment
M02AA07 [21604043]
4.4e-01
—
—
—
—
1.2e+00
—
cases:6.28%
controls:4.16%
—
—
—
—
—
—
—
—
cases:3.93%
controls:1.22%
—
—
12
79
179
1822
—
—
—
—
7
22
171
1785
—
Sarcoidosis of lung with sarcoidosis of lymph nodes
D86.2 [45586127]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
Complicated extraction of tooth
EBA05 [2001301924]
7.6e-01
—
—
—
—
-1.0e+50
1.8e-01
cases:4.19%
controls:2.00%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
cases:3.50%
controls:2.95%
8
38
183
1863
—
—
—
—
0
12
178
1795
5
42
138
1384
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 [2002330113]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.20%
controls:0.00%
—
—
—
—
—
—
6
0
137
1426
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
8.8e-01
-1.0e+50
—
—
—
—
1.2e+00
cases:2.62%
controls:1.10%
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.12%
5
21
186
1880
0
6
191
1895
—
—
—
—
5
16
138
1410
Audiology
64 [38004489]
-2.4e-01
—
—
—
—
—
3.7e-01
cases:2.62%
controls:3.31%
—
—
—
—
—
—
—
—
—
—
cases:5.59%
controls:3.93%
5
63
186
1838
—
—
—
—
—
8
56
135
1370
Other otitis externa
H60.8 [45567109]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1895
—
—
—
—
—
—
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
-4.9e-03
—
—
—
—
1.6e+00
5.0e-01
cases:3.14%
controls:3.16%
—
—
—
—
—
—
—
—
cases:2.81%
controls:0.61%
cases:4.90%
controls:3.02%
6
60
185
1841
—
—
—
—
5
11
173
1796
7
43
136
1383
Insertion or removal of intrauterine contraceptive device
SPAT1190 [2001700291]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
5.3e-01
4.0e-01
-1.0e+50
—
—
8.0e-01
3.1e-01
cases:10.47%
controls:6.47%
cases:6.81%
controls:4.68%
cases:0.00%
controls:0.74%
—
—
—
—
cases:10.11%
controls:4.81%
cases:12.59%
controls:9.54%
20
123
171
1778
13
89
178
1812
0
14
191
1887
—
—
18
87
160
1720
18
136
125
1290
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
191
1888
—
—
—
—
—
—
Cellulitis of other parts of limb
L03.1 [45586760]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
—
Doppler ultrasound examination of heart
FM1DE [2001303299]
7.9e-01
-1.0e+50
—
—
—
—
—
cases:2.62%
controls:1.21%
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
5
23
186
1878
0
12
191
1889
—
—
—
—
—
Other iridocyclitis
H20.8 [45586407]
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:2.81%
controls:0.00%
—
—
—
—
—
—
—
5
0
173
1807
—
Glaucoma secondary to other eye disorders
H40.5 [45571978]
—
—
—
—
—
1.0e+50
1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:5.06%
controls:0.00%
cases:3.50%
controls:0.00%
—
—
—
—
—
9
0
169
1807
5
0
138
1426
Neutrophils [#/volume] in Blood
26499-4 [3017732]
—
—
—
—
—
1.5e+00
8.6e-01
—
—
—
—
—
—
—
—
—
—
cases:3.37%
controls:0.77%
cases:4.20%
controls:1.82%
—
—
—
—
—
6
14
172
1793
6
26
137
1400
Migraine, unspecified
G43.9 [45595943]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
0
7
143
1419
combinations of xanthines
R03DA20 [21603340]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1895
—
—
—
—
—
—
Haemorrhage of anus and rectum
K62.5 [45596339]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
5
143
1421
dexrabeprazole
A02BC07 [45893509]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.19%
—
—
—
—
—
—
0
17
143
1409
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.5e-01
4.3e-01
—
—
—
5.8e-01
7.6e-02
cases:9.95%
controls:7.89%
cases:5.24%
controls:3.47%
—
—
—
—
—
—
cases:6.18%
controls:3.54%
cases:9.09%
controls:8.49%
19
150
172
1751
10
66
181
1835
—
—
—
11
64
167
1743
13
121
130
1305
Calcium [Moles/time] in 24 hour Urine
14637-3 [3010838]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
191
1892
—
—
—
—
—
—
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
6.4e-01
—
—
—
—
—
1.3e+00
cases:3.14%
controls:1.68%
—
—
—
—
—
—
—
—
—
—
cases:4.90%
controls:1.40%
6
32
185
1869
—
—
—
—
—
7
20
136
1406
Prostate symptom/complaint
Y06 [2002001385]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
5
143
1421
Detailed morfological ultrasound examination of fetus
MA2HE [2001306836]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
5
178
1802
—
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
1.0e+00
—
—
—
—
—
—
cases:3.66%
controls:1.37%
—
—
—
—
—
—
—
—
—
—
—
—
7
26
184
1875
—
—
—
—
—
—
Sprain and strain of cervical spine
S13.4 [45573197]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1895
—
—
—
—
—
—
Leukocytes [Presence] in Urine
33052-2 [3045414]
—
-1.0e+50
—
—
—
—
9.3e-01
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.40%
—
0
12
191
1889
—
—
—
—
5
20
138
1406
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.10%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
0
21
191
1880
0
7
191
1894
—
—
—
—
—
rofecoxib; oral
M01AH02 [21603993]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.32%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
0
25
191
1876
—
—
—
—
0
7
178
1800
—
nystatin; oral
A07AA02 [21600604]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
—
0
7
178
1800
—
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60022-1 [40763082]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
0
6
143
1420
Hand Surgery
40 [38004480]
—
—
—
—
—
—
4.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.20%
controls:2.73%
—
—
—
—
—
—
6
39
137
1387
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
3.5e-01
—
-1.0e+50
—
—
—
—
cases:5.24%
controls:3.73%
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
10
71
181
1830
—
0
5
191
1896
—
—
—
—
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
—
-1.0e+50
—
—
—
—
1.0e+00
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.26%
—
0
9
191
1892
—
—
—
—
5
18
138
1408
Gas panel - Arterial blood
24336-0 [3019060]
—
—
—
—
—
—
9.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.40%
—
—
—
—
—
—
5
20
138
1406
Trichilemmal cyst
L72.1 [45596386]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:0.91%
—
—
—
—
—
—
5
13
138
1413
vortioxetine; oral
N06AX26 [44819158]
-1.0e+50
-1.0e+50
-1.0e+50
—
-1.0e+50
-1.0e+50
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.53%
cases:0.00%
controls:0.26%
—
—
cases:0.00%
controls:0.37%
cases:0.00%
controls:0.55%
—
—
0
11
191
1890
0
10
191
1891
0
5
191
1896
—
0
7
191
1887
0
10
178
1797
—
terbinafine; oral
D01BA02 [21601967]
7.4e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:5.24%
controls:2.58%
cases:0.00%
controls:0.58%
—
—
—
—
—
—
cases:0.00%
controls:0.94%
—
—
10
49
181
1852
0
11
191
1890
—
—
—
0
17
178
1790
—
amoxicillin; oral, parenteral
J01CA04 [21602823]
2.5e-01
-1.1e-01
—
—
-1.0e+50
9.0e-02
3.6e-02
cases:24.08%
controls:19.88%
cases:6.28%
controls:6.94%
—
—
—
—
cases:0.00%
controls:0.32%
cases:6.74%
controls:6.20%
cases:20.28%
controls:19.71%
46
378
145
1523
12
132
179
1769
—
—
0
6
191
1888
12
112
166
1695
29
281
114
1145
Other difficulties with micturition
R39.1 [45534441]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
0
7
143
1419
Obesity
T82 [2002001125]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
5
143
1421
Partial excision of meniscus of knee, arthroscopic
NGD05 [2001308109]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
0
11
143
1415
Chronic periodontitis
K05.3 [45586694]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
5
143
1421
atorvastatin; oral
C10AA05 [21601860]
2.5e-01
4.3e-01
5.3e-01
—
3.8e-01
3.2e-01
2.3e-01
cases:14.66%
controls:11.84%
cases:14.14%
controls:9.68%
cases:5.24%
controls:3.16%
—
—
cases:3.66%
controls:2.53%
cases:13.48%
controls:10.13%
cases:16.78%
controls:13.81%
28
225
163
1676
27
184
164
1717
10
60
181
1841
—
7
48
184
1846
24
183
154
1624
24
197
119
1229
Haemorrhagic fever with renal syndrome
A98.5 [45532861]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13967-5 [3004248]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
Orchitis, epididymitis and epididymo-orchitis without abscess
N45.9 [45548671]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
pH of Urine by Test strip
5803-2 [3022621]
—
—
—
—
—
—
6.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.50%
controls:1.82%
—
—
—
—
—
—
5
26
138
1400
Conjunctivitis, unspecified
H10.9 [45591253]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
8
143
1418
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
7.0e-01
—
—
—
—
—
—
cases:2.62%
controls:1.32%
—
—
—
—
—
—
—
—
—
—
—
—
5
25
186
1876
—
—
—
—
—
—
Ingrowing nail
S94 [2002001058]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
5
143
1421
Mild cognitive disorder
F06.7 [45605450]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
0
7
191
1894
—
—
—
—
—
0
5
143
1421
Blepharochalasis
H02.3 [45586340]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.00%
—
—
—
—
—
—
—
—
—
—
—
—
0
19
191
1882
—
—
—
—
—
—
dexbrompheniramine, combinations
R06AB56 [21603469]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
0
9
191
1892
—
—
—
—
0
6
143
1420
Trochanteric bursitis
M70.6 [45606304]
1.0e-01
—
—
—
—
—
—
cases:2.62%
controls:2.37%
—
—
—
—
—
—
—
—
—
—
—
—
5
45
186
1856
—
—
—
—
—
—
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
2.8e-01
—
—
—
-1.0e+50
—
2.3e-01
cases:3.66%
controls:2.79%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
cases:4.90%
controls:3.93%
7
53
184
1848
—
—
—
0
5
191
1889
—
7
56
136
1370
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
191
1892
—
—
—
—
—
—
Instability of the detrusor vesicae muscle
N32.82 [2000503170]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
—
Very extensive body CT
JN4CD [2001310902]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
—
Shoulder region
ZA1.0 [2000503738]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
0
6
143
1420
Overall medication plan or its review
SPAT1252 [2001700353]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
—
0
9
191
1892
—
—
—
—
—
Application of soft bandage
SPAT1211 [2001700312]
1.0e+00
-1.0e+50
—
—
—
—
—
cases:3.14%
controls:1.16%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
6
22
185
1879
0
7
191
1894
—
—
—
—
—
Treatment plan or consultation
WZC00 [2001310885]
7.2e-01
—
—
—
—
—
6.6e-01
cases:9.42%
controls:4.84%
—
—
—
—
—
—
—
—
—
—
cases:7.69%
controls:4.14%
18
92
173
1809
—
—
—
—
—
11
59
132
1367
Proctoscopy
UJG02 [2001305126]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
losartan and diuretics
C09DA01 [21601834]
-2.2e-01
—
-1.0e+50
—
—
8.7e-02
-5.4e-02
cases:3.14%
controls:3.89%
—
—
cases:0.00%
controls:0.84%
—
—
—
—
cases:3.37%
controls:3.10%
cases:4.20%
controls:4.42%
6
74
185
1827
—
0
16
191
1885
—
—
6
56
172
1751
6
63
137
1363
levomepromazine; oral, parenteral
N05AA02 [21604493]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
cases:0.00%
controls:0.35%
—
—
—
—
—
0
5
178
1802
0
5
143
1421
Malignant neoplasm of breast
C50 [45571518]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.79%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
0
15
191
1886
0
5
191
1896
—
—
—
—
—
Incontinence urine
U04 [2002001139]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.53%
—
—
—
—
—
—
cases:0.00%
controls:0.39%
cases:0.00%
controls:0.77%
—
0
10
191
1891
—
—
—
0
7
178
1800
0
11
143
1415
Digoxin [Moles/volume] in Serum or Plasma
14698-5 [3027456]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
cases:0.00%
controls:0.84%
0
9
191
1892
—
—
—
—
0
7
178
1800
0
12
143
1414
Burn/scald
S14 [2002000979]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
0
6
143
1420
Gout
T92 [2002001133]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60477-7 [40763531]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1896
—
—
—
—
—
—
eprosartan; oral
C09CA02 [21601825]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
—
0
5
178
1802
—
Glucose tolerance test outside reference range
274858002 [440216]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1895
—
—
—
—
—
—
Flap of skin
ZZR00 [2001311677]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1894
—
—
—
—
—
—
Depressive episode, unspecified
F32.9 [45571760]
8.9e-01
—
—
—
—
—
—
cases:3.14%
controls:1.32%
—
—
—
—
—
—
—
—
—
—
—
—
6
25
185
1876
—
—
—
—
—
—

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
76
260
4.02
19.58
3.0
2.1
—
—
—
0
0
19
12
17.27
12.40
1.2
1.5
—
—
—
0
0
19
14
14.79
11.71
2.3
3.0
16.34
—
iu/ml
—
5
0
15
8
20.07
10.42
1.1
1.3
—
—
—
0
0
22
48
5.00
9.78
1.2
1.1
—
—
—
0
0
17
16
11.45
9.48
1.2
1.3
—
—
—
0
0
48
201
2.80
8.19
2.2
1.8
—
—
—
0
0
49
212
2.71
7.83
2.4
1.4
—
—
—
0
0
11
6
19.25
7.68
1.0
1.0
2109.09
1537.83
miu/ml
—
11
6
10
6
17.40
6.81
3.4
1.8
542.50
1203.83
u/ml
—
10
6
27
107
2.75
5.03
1.6
1.8
—
—
—
0
0
44
233
2.13
4.35
14.9
5.1
1.03
1.04
mmol/l
0.11
44
210
80
538
1.79
3.87
6.3
4.2
—
—
—
0
0
85
582
1.78
3.87
7.8
4.0
7.40
7.40
ph
0.06
65
399
46
261
1.98
3.76
2.1
1.8
—
—
—
0
0
9
16
5.82
3.70
2.2
1.9
38.46
40.19
%
—
9
16
40
220
2.01
3.55
1.4
1.4
680.00
415.27
titre
—
6
55
31
158
2.13
3.36
3.1
2.1
0.00
0.00
estimate
—
5
35
114
875
1.67
3.26
10.9
6.0
0.59
0.58
e9/l
0.19
105
749
24
112
2.29
3.21
1.8
1.5
—
—
—
0
0
114
878
1.66
3.20
11.0
6.0
0.04
0.04
e9/l
0.20
105
753
19
80
2.51
3.16
2.8
2.0
0.00
0.00
estimate
—
7
26
117
910
1.65
3.13
11.4
6.4
0.19
0.19
e9/l
0.18
110
792
101
759
1.64
3.09
17.0
13.0
0.00
0.00
e9/l
0.60
87
626
122
962
1.64
3.07
6.9
4.2
0.00
0.00
estimate
-0.00
28
207
5
5
10.20
2.99
3.2
1.6
25.20
28.40
%
—
5
5
114
891
1.61
2.92
11.0
6.1
1.74
1.90
e9/l
0.64
106
791
108
839
1.59
2.80
8.2
4.5
34.71
35.42
g/l
0.68
101
779
6
10
6.14
2.71
3.8
1.4
178.67
57.36
ng/l
—
6
10
121
972
1.58
2.67
6.9
4.2
0.00
0.00
estimate
-0.00
26
193
20
95
2.22
2.58
1.0
1.2
—
—
—
0
0
5
7
7.28
2.56
2.8
2.0
—
—
—
0
0
118
951
1.55
2.51
6.1
4.1
0.00
0.00
estimate
-0.00
26
204
8
21
3.92
2.49
2.4
2.0
820.12
1059.44
e6/l
—
8
16
26
140
1.98
2.45
6.0
3.0
10.41
10.16
g/l
0.07
26
126
25
133
2.00
2.44
3.1
2.9
206.88
226.22
ng/l
0.07
25
117
54
368
1.63
2.34
4.9
3.7
46.32
202.12
ng/l
1.27
41
303
81
609
1.54
2.31
5.7
3.5
—
—
—
0
0
5
9
5.66
2.22
1.0
1.0
—
—
—
0
0
79
597
1.52
2.18
5.6
4.0
16.31
8.57
mg/mmol
0.62
58
371
6
14
4.38
2.16
1.3
1.1
—
—
—
0
0
6
14
4.38
2.16
3.3
4.1
—
—
—
0
0
115
942
1.49
2.13
13.9
6.6
1.22
1.21
mmol/l
0.28
102
818
110
893
1.49
2.13
19.7
15.8
1.31
1.29
inr
0.13
99
750
7
20
3.58
2.07
1.4
1.6
—
—
—
0
0
21
112
1.97
2.05
4.1
1.8
2.04
1.27
g/l
0.35
21
99
22
120
1.93
2.02
8.5
3.6
—
—
—
0
0
75
571
1.49
1.96
9.8
5.7
—
—
—
0
0
9
33
2.80
1.95
1.1
1.7
—
—
—
0
0
5
11
4.63
1.95
5.8
1.5
2.84
1.56
mmol/l
—
5
11
71
536
1.49
1.93
12.1
5.7
—
—
—
0
0
78
601
1.48
1.92
5.6
3.2
6.74
7.48
mmol/l
0.67
72
498
149
1301
1.51
1.92
5.2
4.4
15.06
15.04
pmol/l
0.04
135
1159
7
22
3.25
1.89
1.6
1.4
—
—
—
0
0
43
605
0.64
1.89
4.3
3.5
—
—
—
0
0
100
812
1.44
1.86
4.0
3.0
—
—
estimate
—
0
0
12
53
2.34
1.84
1.2
1.1
—
—
—
0
0
95
765
1.44
1.84
4.7
4.3
40.72
39.82
ng/l
0.03
69
572
73
560
1.47
1.82
1.7
1.7
21.67
21.35
nmol/l
0.03
65
454
96
776
1.44
1.82
5.7
3.8
6.49
6.26
ph
1.44
49
421
34
221
1.64
1.77
2.3
1.6
—
—
—
0
0
27
165
1.73
1.75
6.9
5.1
0.23
0.00
%
1.09
13
51
28
173
1.71
1.75
2.5
1.6
—
—
—
0
0
139
1210
1.44
1.71
7.7
4.8
—
2.34
—
0
6
74
575
1.44
1.71
5.1
3.3
60.74
51.99
mg/l
0.14
53
377
12
55
2.25
1.71
8.4
4.0
1.13
2.70
ratio
—
5
31
10
41
2.51
1.67
1.7
1.3
—
—
—
0
0
5
14
3.63
1.62
1.0
1.2
121.80
102.29
pmol/l
—
5
14
118
1006
1.40
1.58
14.5
9.9
4.05
4.24
e9/l
0.47
108
875
7
27
2.65
1.53
1.6
1.0
—
—
—
0
0
83
670
1.40
1.52
2.5
2.1
—
—
—
0
0
25
156
1.68
1.52
6.1
4.6
0.17
0.42
%
1.12
12
53
9
38
2.43
1.47
1.2
1.7
4.31
3.79
mmol/l
—
9
38
13
66
2.03
1.47
1.6
3.0
432.43
217.17
mg/l
—
7
24
9
40
2.31
1.42
2.9
2.2
—
—
—
0
0
89
736
1.36
1.39
5.8
4.1
0.00
0.03
estimate
0.78
20
167
25
161
1.63
1.36
6.2
4.8
0.08
0.15
%
0.28
12
53
152
1370
1.40
1.36
33.8
22.1
13.84
13.78
%
0.25
152
1355
14
76
1.90
1.33
2.6
1.9
—
—
—
0
0
23
146
1.65
1.33
1.1
1.4
—
—
—
0
0
12
62
1.99
1.30
3.1
2.5
21.33
20.70
s
0.34
12
56
63
497
1.38
1.30
3.1
2.2
2.62
3.08
mg/l
0.54
58
436
54
415
1.41
1.30
8.4
4.3
1.02
1.02
kg/l
0.66
40
264
10
48
2.14
1.30
1.3
1.6
434.40
472.33
mg/l
—
10
48
5
18
2.82
1.29
1.2
1.1
—
—
—
0
0
99
841
1.34
1.27
2.3
2.1
95.17
97.49
pmol/l
0.17
57
403
24
158
1.59
1.21
2.3
2.2
0.21
0.21
g/l
0.05
24
145
12
64
1.93
1.20
24.9
14.4
—
—
—
0
0
8
38
2.15
1.20
4.1
2.7
4.21
4.04
mmol/l
—
8
38
8
38
2.15
1.20
4.1
2.7
102.75
105.92
mmol/l
—
8
38
8
38
2.15
1.20
4.1
2.7
1.17
1.21
mmol/l
—
8
38
62
497
1.35
1.15
5.3
3.4
—
0.00
—
0
15
5
21
2.41
1.09
1.0
1.9
91.36
89.09
%
—
5
21
178
1670
1.44
1.08
27.8
17.2
24.56
25.32
mg/l
0.11
153
1379
25
172
1.52
1.06
6.2
4.7
0.17
0.90
%
3.30
12
64
58
466
1.34
1.06
1.3
1.4
—
—
—
0
0
82
694
1.30
1.03
6.8
4.0
132.47
116.70
e6/l
0.10
60
487
66
544
1.31
1.01
6.6
4.1
0.00
0.01
estimate
0.50
27
186
50
398
1.34
0.97
7.9
5.5
—
—
—
0
0
55
448
1.31
0.91
7.2
3.8
89.91
88.39
%
0.14
55
442
79
675
1.27
0.91
4.0
3.1
2.34
2.35
mmol/l
0.43
70
609
10
56
1.83
0.89
4.7
2.6
24.65
24.96
mmol/l
—
10
49
8
44
1.85
0.87
1.3
1.6
3.75
35.32
e6/l
—
8
31
18
121
1.53
0.86
7.9
2.8
0.97
1.26
%
1.31
18
121
8
45
1.81
0.85
1.4
1.7
888.88
147.94
e6/l
—
8
33
10
57
1.79
0.85
7.1
2.8
1.71
1.46
mg/l
—
10
46
28
207
1.41
0.85
11.9
4.1
7.38
7.38
ph
0.43
20
133
30
226
1.38
0.82
9.3
6.1
0.33
1.02
mmol/l
0.32
22
185
31
235
1.37
0.82
8.9
5.9
7.44
7.42
ph
0.80
18
137
6
34
1.79
0.77
5.5
2.3
10.50
10.50
mmol/l
—
6
34
67
575
1.24
0.73
3.9
2.6
—
—
—
0
0
9
143
0.61
0.72
1.2
1.5
—
—
—
0
0
5
26
1.95
0.71
1.2
1.0
—
—
—
0
0
5
26
1.95
0.71
13.8
1.3
—
—
—
0
0
146
1362
1.24
0.70
36.8
23.0
331.53
331.36
g/l
0.09
146
1357
7
42
1.69
0.69
2.6
2.5
—
—
—
0
0
178
1701
1.31
0.68
23.6
15.4
—
—
—
0
0
63
541
1.24
0.68
6.0
3.7
0.00
0.00
estimate
-0.00
22
166
14
95
1.51
0.66
14.2
4.3
0.84
0.83
%
0.02
14
90
15
210
0.69
0.65
3.6
2.3
90.40
132.50
ug/g
—
10
168
20
148
1.39
0.62
3.7
3.1
—
—
—
0
0
5
30
1.68
0.62
3.8
1.4
—
—
—
0
0
5
30
1.68
0.62
3.8
1.4
—
—
—
0
0
5
30
1.68
0.62
3.8
1.4
—
—
—
0
0
5
30
1.68
0.62
3.8
1.4
—
—
—
0
0
23
175
1.35
0.61
1.6
2.5
5.97
5.30
ug/l
0.14
23
152
49
414
1.24
0.61
2.2
1.8
1.38
1.42
mg/l
0.04
40
336
0
20
0.00
0.60
0.0
1.7
—
8.27
—
0
20
50
424
1.24
0.60
6.4
4.0
—
0.33
—
0
6
6
36
1.69
0.57
1.5
2.3
10.92
9.53
pmol/l
—
6
36
16
116
1.41
0.56
5.4
2.5
5.49
5.02
kpa
0.50
16
108
70
620
1.19
0.55
5.6
3.3
29.13
141.91
e6/l
0.54
61
469
77
688
1.19
0.55
2.4
2.0
1.44
1.30
mmol/l
0.70
66
561
9
62
1.47
0.54
11.8
5.9
—
—
—
0
0
9
65
1.40
0.51
1.1
1.1
—
—
—
0
0
165
1580
1.21
0.49
9.1
6.7
41.51
39.87
mmol/mol
1.13
156
1470
11
76
1.47
0.49
6.9
2.4
—
—
—
0
0
14
102
1.40
0.48
14.5
4.2
1.54
1.46
%
0.25
14
96
7
47
1.51
0.48
10.1
1.3
—
—
—
0
0
7
47
1.51
0.48
10.1
1.3
—
—
—
0
0
7
48
1.47
0.47
10.1
1.3
—
—
—
0
0
7
48
1.47
0.47
10.1
1.3
—
—
—
0
0
7
49
1.44
0.46
10.4
1.3
—
—
—
0
0
36
306
1.21
0.43
1.4
1.3
62.45
45.33
iu/ml
0.22
11
97
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
2.8
—
—
—
0
0
17
214
0.78
0.40
1.3
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
37.04
—
0
19
5
37
1.36
0.37
4.2
3.0
7.92
7.93
kpa
—
5
37
5
37
1.36
0.37
4.2
3.0
4.60
5.03
kpa
—
5
37
6
44
1.37
0.34
1.3
1.3
67.38
405.12
pmol/l
—
6
44
34
298
1.17
0.31
5.0
3.1
1.96
3.04
e6/l
0.56
22
149
59
539
1.13
0.31
5.3
3.2
0.17
0.35
e6/l
1.55
51
395
45
404
1.15
0.30
1.8
1.9
431.03
445.62
pmol/l
0.11
38
333
18
216
0.82
0.30
2.6
3.9
2.33
40.52
ug/l
0.62
12
174
10
76
1.33
0.28
2.8
1.5
0.52
0.29
mg/l
—
5
30
160
1552
1.13
0.28
4.9
4.4
1.24
1.24
mmol/l
0.03
149
1401
160
1553
1.13
0.28
6.9
5.5
2.02
1.97
mu/l
0.20
152
1399
8
66
1.22
0.27
3.9
3.2
—
—
—
0
0
22
188
1.19
0.26
1.4
2.0
403.00
384.48
nmol/l
0.23
22
172
21
242
0.85
0.23
1.6
1.2
—
—
—
0
0
24
210
1.16
0.23
10.3
6.2
95.84
95.64
%
0.08
24
204
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
166
1626
1.10
0.19
5.9
5.3
4.30
4.53
mmol/l
2.46
157
1487
56
526
1.09
0.18
4.9
5.6
5.06
2.66
ug/l
0.39
50
468
169
1659
1.10
0.17
6.8
6.0
2.38
2.60
mmol/l
3.38
159
1515
12
141
0.84
0.17
3.8
1.6
—
—
—
0
0
14
120
1.18
0.17
7.8
5.8
23.23
24.87
mmol/l
0.98
14
120
16
139
1.16
0.17
1.3
1.2
—
—
—
0
0
39
365
1.08
0.13
2.3
1.5
2.61
2.58
g/l
0.02
29
198
19
171
1.12
0.13
15.9
6.7
—
—
—
0
0
24
220
1.10
0.12
1.7
1.3
—
—
—
0
0
34
318
1.08
0.12
3.3
3.3
0.54
0.81
ug/l
1.78
24
201
164
1616
1.07
0.11
5.7
5.1
1.46
1.48
mmol/l
0.21
155
1468
13
115
1.14
0.11
1.7
1.3
—
—
—
0
0
39
411
0.94
0.10
1.3
1.3
0.79
2.21
u/ml
—
7
108
5
44
1.14
0.10
6.8
2.6
54.20
60.84
%
—
5
44
160
1621
0.94
0.09
6.4
5.3
6.17
6.00
mmol/l
0.88
153
1468
26
277
0.93
0.08
1.5
1.3
1.31
12.74
u/ml
—
8
98
6
57
1.05
0.08
4.3
2.9
7.42
7.41
ph
—
6
57
9
84
1.07
0.07
1.2
1.3
—
—
—
0
0
50
483
1.05
0.07
4.0
2.9
361.09
349.87
umol/l
0.30
44
404
13
140
0.92
0.04
3.2
4.2
—
—
—
0
0
15
156
0.96
0.00
9.9
4.0
7.34
7.33
ph
0.12
15
108
10
99
1.01
0.00
1.1
1.3
55.19
335.33
u/ml
—
10
94
22
223
0.98
0.00
2.8
2.5
5.32
8.25
umol/l
1.13
22
193
5
55
0.91
0.00
1.0
1.3
0.21
0.23
g/l
—
5
55
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.1
—
63.25
—
0
8
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
7.76
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
18.34
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
37.74
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_OTHENDOPHTHALMITIS and mortality.

Females

Parameter HR [95% CI] p-value
H7_OTHENDOPHTHALMITIS 1.387 [1.15, 1.67] < 0.001
Birth year 0.991 [0.98, 1.0] 0.049

During the follow-up period (1.1.1998 — 31.12.2019), 280 out of 691 females with H7_OTHENDOPHTHALMITIS died.

Males

Parameter HR [95% CI] p-value
H7_OTHENDOPHTHALMITIS 1.786 [1.39, 2.3] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 230 out of 557 males with H7_OTHENDOPHTHALMITIS died.

Mortality risk

Mortality risk for people of age

years, who have H7_OTHENDOPHTHALMITIS.

N-year risk Females Males
1 0.091% 0.253%
5 0.739% 1.803%
10 1.913% 4.433%
15 3.556% 8.403%
20 6.099% 13.372%

Relationships between endpoints

↥

Index endpoint: H7_OTHENDOPHTHALMITIS – Other endophthalmitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data